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SUMMARY OF THE THESIS 
Osteoporotic fractures are associated with morbidity and increased 
mortality, and treating fractures is an increasing expenditure for national 
health systems. Targeting fracture preventative measures appropriately 
starts with finding those at risk of fracture, services for which can be 
expensive and poorly available. Metacarpal morphometry can potentially 
be an inexpensive and widely available method of skeletal strength 
assessment. In this study a semi-automated metacarpal morphometry 
(SMCM) technique and a fully automated digital x-ray radiogrammetry 
(OXR) technique were studied for fracture prediction ability. 
9 
OXR was studied in a nested case-control setting with hip fracture patients 
and controls (Hip fracture Prevention Study, HIPS), and OXR bone mineral 
density (BMO) and OXR metacarpal index (MCI) were found to predict hip 
fracture risk (odds ratio, OR 1.79 and 1.72 respectively for 1 standard 
deviation (SO) decrease in measurement). OXR was also studied in a 
prospective setting for vertebral fracture prediction (Vertebral Osteoporosis 
Trial), and OXR-BMO and OXR-MCI were found to predict vertebral 
fracture risk (OR 1.56 and 1.81 respectively). SMCM was studied in a 
prospective setting (HIPS), and average MCI of 6 metacarpals (AMCI) was 
found to predict all fracture risk and hip fracture risk (OR 1.30 and 1.42 
respectively), but not clinical vertebral fracture risk. In all these settings 
however, hip, spinal and forearm OXA measures had similar or higher 
point estimates for the respective fracture risk predictions. There was a 
trend for disproportionately greater bone loss with age at the metacarpals 
by MCM measures, compared to hip or forearm OXA measures, especially 
when associated with other medical conditions such as rheumatoid 
arthritis. 
Although MCM measures were not superior to OXA measures in fracture 
risk prediction, there may be a useful role for them in epidemiological 
studies or providing a clinical service where access to OXA is limited. 
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1 INTRODUCTION 
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The research towards this dissertation was conceived and undertaken 
between November 2001 and October 2003 at Sheffield, United Kingdom 
while I was a clinical research fellow at the University of Sheffield. 
1.1 UNIVERSITY OF SHEFFIELD MEDICAL SCHOOL 
The medical school traces its roots back to the Sheffield School of 
Medicine founded in 1828, which became part of the University College 
Sheffield founded in 1897. This eventually became the University of 
Sheffield following a Royal Charter granted in May 1905. 
At present the Medical School has more than one thousand students 
training at various undergraduate and postgraduate levels. Following the 
2008 Research Assessment Exercise, the government's independent 
Research Rating for the school is 5 - indicating that most of its research is 
of international standing, and all is of at least national importance, leading 
to the ranking of 11th out of 20 Russell Group medical schools. 
The School's activities integrate teaching, research and the practice of 
medicine, in collaboration with the Primary and the Secondary care 
providers in the region. As such, several departments are Clinically 
integrated with the Sheffield Teaching Hospitals NHS Foundation Trust. 
The two main hospital sites of the Trust in Sheffield are the Royal 
Hallamshire Hospital and the Northern General Hospital. Both these 
hospital sites also house several departments and laboratories affiliated to 
the medical school. Generally, these departments are integrated in such a 
Metacarpal Radiographic Indices In Bone Assessment 
way with the clinical departments that they are not only involved in 
teaching and research, but also provide frontline clinical services. 
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1.2 SHEFFIELD METABOLIC BONE UNIT AND THE 
WORLD HEALTH ORGANISA TION COLLABORA TING 
CENTRE FOR METABOLIC BONE DISEASES 
When this research was started in 2001, the WHO Collaborating Centre 
for Metabolic Bone Diseases (University of Sheffield, Director: Prof. John 
Kanis) was based in the Sheffield Metabolic Bone Unit at the Royal 
Hallamshire Hospital site. The research was undertaken under the 
supervision of Dr. Eugene McCloskey, who was at the time Senior 
Research Fellow affiliated to the WHO Collaborating Centre for Metabolic 
Bone Diseases. 
The Centre had several University employees engaged in research, who 
simultaneously also provided a regional clinical service for patients 
attending for the diagnosis and management of osteoporosis and other 
metabolic bone diseases. Facilities included several scanners for 
assessment of bone, and full haematology and biochemistry laboratory 
facilities through the Hospital for the assessment of bone including bone 
turnover markers. 
Scanning systems available at the Centre included dual-energy x-ray 
absorptiometry (for research and clinical use), ultrasound (for research), 
digital x-ray radiogrammetry (for research) and a semi-automated 
metacarpal morphometry system (for research). 
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At the time this research was started, a clinical service for osteoporosis 
and other metabolic bone diseases was also being provided from the 
Sorby Wing, Northern General Hospital site by the team led by Prof. 
Richard Eastell, head of the Academic Unit of Bone Metabolism, University 
of Sheffield. 
1.3 METABOLIC BONE CENTRE, NORTHERN GENERAL 
HOSPITAL 
A review of the osteoporosis clinical services for the region in 2002 
resulted in a decision to merge the services delivered from the Royal 
Hallamshire Hospital and the Northern General Hospital sites in 2003. 
Both clinical services, along with staff offices and the clinical research 
fellows' office, were moved to a newly refurbished block on the Northern 
General Hospital site in mid-2003. 
1.4 CLINICAL RESEARCH FELLOWSHIP & DISSERTATION 
Most of the work, including the analyses, for this research was performed 
when I was based at the Royal Hallamshire Hospital. During this time I 
also had twice weekly booked clinic lists towards subspecialist clinical 
training in bone medicine. Some of the final analyses and most of the 
writing up of the dissertation took place when I was based at the Northern 
General Hospital site. During this time I also gave medical support to the 
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Clinical Trials Unit of the Metabolic Bone Centre in recruiting patients etc, 
along with occasional clinical work. 
All the main analyses from this research were submitted, accepted and 
presented at various national or international bone meetings, and 
published as abstracts in the relevant supplements as listed at the 
beginning of the dissertation. 
The several analyses that comprise this work are grouped into four main 
projects. This thesis is organised into several chapters: background, 
leading on to the hypothesis and objectives; followed by description of the 
four projects; and ending in a final summary and overall conclusions. 
Although the background chapter is applicable to the whole thesis, each of 
the projects is also written up to be individually complete and 
independently read, incorporating an abstract and introduction relevant to 
that project. Where this has entailed repetition, every effort has been 
made to ensure that this is relevant and kept to a minimum. 
"EndNote 5" software ((lSI ResearchSoft, Berkeley, USA; licensed by 
University of Sheffield) was used through out to incorporate references in 
the text and collate them in the 'References' chapter at the end of the 
dissertation. 
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2 BACKGROUND 
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2.1 NORMAL BONE AND OSTEOPOROSIS 
The skeletal system is comprised of bone and cartilage, which are 
specialised connective tissues. It serves three main functions: integral to 
posture and locomotion; protection of vital organs and bone marrow; and a 
reserve of ions in calcium and phosphate metabolism essential for 
maintaining homeostasis. 
2.1.1 NORMAL BONE ANATOMY 
Bone can be classified in several ways depending on the aspect of bone 
that is being described or studied (Soames 1995). Developmentally, bone 
formation can happen in two ways: a) 'intramembranous', by direct 
transformation of condensed mesenchymal tissue or b) 'endochondral', 
preceded by a cartilage model which is later replaced by bone (Soames 
1995). Based on shape, bones have been classified as: a) flat bones, ego 
skull, pelvis and ribs; b) long (or tubular) bones, ego long tubular bones of 
the limbs, and small tubular bones of the hands and feet, such as the 
phalanges, metacarpals, and metatarsals; and c) irregular bones, bones of 
the face and vertebral column. Other types are 'short' bones of the carpus 
and tarsus, and sesamoid and accessory bones (Soames 1995). 
The 'intramembranous' development is typically seen in flat bones such as 
the skull. Although typically long bones are taught in medical school to be 
a result of 'endochondral' development, long bone development actually 
involves both types of processes (Baron 1999). 
Gross inspection of a long tubular bone typically reveals the following 
structure: the epiphyses, which are the two wider extremities; the 
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diaphysis, a nearly cylindrical tube in the middle; and the metaphysis, a 
developmental zone between the epiphysis and diaphysis. In a 
longitudinal section, the outer layer of the bone is a thick dense layer of 
calcified tissue called the 'cortex' (compact bone), and this is thickest in 
the diaphysis enclosing the medullary cavity housing the bone marrow. 
The cortex becomes progressively thinner towards the metaphysis and 
epiphysis, with the internal space filled by a network of thin calcified 
trabeculae called 'trabecular bone' (cancellous bone). The bone is 
therefore in contact with soft tissues on two surfaces: an external or 
'periosteal' surface, and an internal 'endosteal' surface, both of which are 
lined with osteogenic cell layers, the 'periosteum' and the 'endosteum' 
(Baron 1999). 
2.1.2 NORMAL BONE HISTOLOGY 
Bone is composed of a number of different types of cells embedded in a 
calcified matrix. The matrix consists of collagen fibres (type I, 90% of total 
protein) oriented in a preferential fashion in a ground substance primarily 
composed of glycoproteins and proteoglycans. Calcium hydroxyapatite 
crystals, in spindle or plate shapes are found on the collagen fibres, within 
them and in the ground substance usually oriented in the same direction 
as the collagen fibres (Soames 1995; Baron 1999). 
The cell types include osteoprogenitor stromal cells which give rise to 
other bone cells, osteoblasts which lay down bone, osteocytes within 
bone, osteoclasts which erode it, and lining cells on bone surface. The 
osteoblast arises from the stromal cell, is a bone-lining cell and is 
responsible for the production of collagen and ground SUbstance of the 
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matrix (Lian, Stein et al. 1999). The osteoclast is a giant multinucleated 
cell (4-20 nucleii), is a bone lining cell, and is responsible for bone 
resorption (Soames 1995; Baron 1999). Osteocytes are cells which were 
originally osteoblasts which became trapped in the bone matrix they 
produced but these cells are in contact through cell processes and gap 
junctions with other osteocytes and bone-lining cells including osteoblasts, 
through a network of thin canaliculi permeating the entire bone matrix. The 
actions of biomechanical forces on bone are sensed by this osteocyte 
syncytium within bone via the canalicular network and intercellular gap 
junctions (Baron 1999; Clarke 2008). 
2.1.3 BONE PHYSIOLOGY AND REMODELLING 
Osteoblasts are found in clusters of cuboidal cells along the bone surface, 
usually 100-400 cells per bone-forming site. A mature, active osteoblast 
secretes type I collagen and specialised bone matrix proteins as osteoid in 
the direction of the mineralising front of the issue. A number of hormones, 
cytokines and other polypeptide skeletal growth factors are involved in the 
regulation of bone formation by their complex actions on osteoprogenitor 
cells and osteoblasts (Lian, Stein et al. 1999; Caetano-Lopes, Canhao et 
al. 2007). 
Osteoclasts are found singly or in clusters of up to 5 cells, in contact with a 
calcified bone surface in a bed of elliptic or fusiform spindle shaped lining 
cells. Activated osteoclasts actively synthesize and secrete lysosomal 
enzymes and metallo-proteinases into a sealed off compartment on the 
adjacent bone surface along with acidification of the compartment. The 
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low pH dissolves the crystals exposing the matrix, which allows the 
enzymes to degrade the matrix components (Saron 1999). 
Osteoblasts also influence bone resorption through receptor activator of 
nuclear factor-kappaS (RANK) ligand (RANKL) that links to its receptor, 
RANK, on the surface of osteoclasts and osteoclast-precursor cells, 
inducing their differentiation and fusion. Osteoblasts secrete a soluble 
decoy receptor (osteoprotegerin, OPG) that blocks RANKIRANKL 
interaction by binding to RANKL and, thus, prevents osteoclast 
differentiation and activation. Therefore, the balance between RANKL and 
OPG determines the formation and activity of osteoclasts (Hsu, Laceyet 
al. 1999; Caetano-Lopes, Canhao et al. 2007). 
Sone "remodelling" is a process involving the coordinated actions of 
osteoclasts, osteoblasts, osteocytes within the bone matrix and 
osteoblast-derived lining cells that cover the surface of bone resulting in 
the removal of old bone and synthesis of new bone, thereby maintaining 
the structural integrity and the dynamic nature of the skeleton. The 
process is accomplished by assembly of osteoclasts and osteoblasts into 
discrete temporary anatomic structures called basic multicellular units 
(SMUs) (Jilka 2003). Remodelling starts with signals that initiate osteoclast 
formation followed by osteoclast-mediated bone resorption, a reversal 
period, and then a period of bone matrix formation mediated by 
osteoblasts, followed by mineralisation of the matrix (Mundy 1999; Sims 
and Gooi 2008). 
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2.1.4 BONE EVOLUTION WITH AGE 
During growth, bone modelling and continuous remodelling optimize 
strength, by depositing bone where it is needed, and minimize mass, by 
removing it from where it is not. Cortical bone forms around 85% of total 
bone in the body of an adult. In adulthood cortical bone is removed mainly 
by endosteal resorption and resorption within the haversian canals. The 
latter leads to increased porosity of the bone. However, periosteal bone 
formation continues throughout life resulting in the increase in diameter of 
cortical bone, which confers a geometric property of increased rigidity 
reducing the fragility of slenderness (Rubin and Rubin 1999; Seeman 
2008). Cancellous bone comprises around 15% of the skeleton, and 
remodeling is considered to be subtly different to the process in cortical 
bone. Bone remodeling cells in cancellous bone are in intimate contact 
with the cells of the marrow cavity, which produce potent osteotropic 
cytokines. These can potentially affect remodeling in cancellous bone, 
while systemic osteotropic hormones such as parathyroid hormone and 
1,25-dihydroxy vitamin 03 have been thought to affect the remodeling 
process to a greater extent in cortical bone (Mundy 1999). 
The net mass of bone is maintained at a relatively stable level by bone 
remodelling in younger adults. However, this balance is disturbed as age 
progresses: cortical bone loss probably begins to occur after the age 40 
years, with cancellous bone loss probably beginning somewhat earlier, 
with variable acceleration of the bone loss at the time of menopause 
(Mundy 1999; Martin and Seeman 2008; Seeman 2008). 
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2.1.5 OSTEOPOROSIS 
When the imbalance in bone formation and resorption persists (either age 
related, or due to other conditions), the continuing bone loss eventually 
results in osteoporosis. 
In 1993 a consensus conference defined osteoporosis as a metabolic 
bone disease characterised by low bone mass and microarchitectural 
deterioration of bone tissue, leading to enhanced bone fragility and a 
consequent increase in fracture risk (Consensus Development 
Conference) (1993). In 2000 a National Institutes of Health (NIH) 
consensus development conference defined osteoporosis as a skeletal 
disorder characterized by compromised bone strength predisposing to an 
increased risk of fracture (NIH Consensus Development Panel) (2001). 
For purposes of demographics and prevalence estimates, the World 
Health Organisation (WHO) classified patients according to bone mineral 
density (BMD) values and published the information in 1994 (Kanis 1994). 
These reference ranges are based on population distributions and were 
not specifically developed for clinical decision-making in the treatment of 
individual patients. According to this classification, the general diagnostic 
categories are: 
• Normal: BMD or bone mineral content (BMC) not more than 1 SO 
below the young adult mean (T-score above -1). 
• Osteopenia (or low bone mass): BMD or BMC between 1 and 2.5 SO 
below young adult mean (T-score between -1 and -2.5). 
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• Osteoporosis: BMO or BMC 2.5 SO or more below the young adult 
mean (T-score at or below -2.5). 
• Severe osteoporosis (or established osteoporosis): BMO or BMC 2.5 
SO or more below the young adult mean in the presence of one or 
more fragility fractures. 
Osteoporosis is the commonest metabolic bone disease in the UK and 
other developed countries. Osteoporotic fractures increase with age with 
hip fractures showing a rising incidence in the 70s, vertebral fractures in 
the 60s and wrist fractures in the 50s (Wasnich 1999). In this setting, 
understanding the issues surrounding bone strength and fracture risk have 
become subjects of interest for study and research, with the eventual 
objective that better understanding will lead to better preventative and 
treatment strategies for reducing fracture risk. 
2.2 BONE STRENGTH AND FRACTURE RISK 
Bone strength and risk of fracture (or ultimate failure of bone) have an 
inverse relationship: the lower the bone strength, the higher the risk of the 
bone failing under a given stress or strain (Rubin and Rubin 1999). It might 
therefore be assumed that the understanding of bone strength can give 
insights into fracture risk and vice-versa. However, in a clinical setting, the 
relationship may not be so straightforward, and issues affecting bone 
strength may not be the only factors influencing fracture risk. Conversely, 
issues affecting fracture risk may not all be relevant to the determination of 
bone strength. Nevertheless, modification of bone strength remains the 
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main objective in identifying or designing interventions to reduce fracture 
risk (Friedman 2006). 
2.2.1 DETERMINANTS OF BONE STRENGTH 
Traditionally, BMD measurement has been used as a surrogate marker for 
prediction of fracture risk and to decide on treatment. However, there has 
been long recognition that BMD measurements only account for 60-70% 
of the variation in bone strength. Bone strength is now known to be 
determined by its material and structural properties such as bone 
geometry, cortical thickness and porosity, trabecular bone morphology, 
and intrinsic properties of bony tissue (Ammann and Rizzoli 2003). This 
realization has led to the development of the concept of bone quality which 
can be understood as an umbrella term that describes the set of 
characteristics that influence bone strength and explains the 
interrelationships of these characteristics (Felsenberg and Boonen 2005). 
Currently therefore, bone strength can be thought of as a composite 
expression of bone mineral density, bone quality, and bone geometry with 
respect to biomechanics. 
2.2.2 GENETIC AND CLINICAL FACTORS 
Although bone quality is a relatively recent concept, several genetic and 
clinical factors have already been known to influence BMD and fracture 
risk. For example, age, gender, ethnicity, family history (particularly 
maternal hip fracture), smoking, alcohol consumption etc have been 
shown to be risk factors for fracture (Wasnich 1999). Some of these 
factors not only influence BMD, but are also known to influence fracture 
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risk independent of BMD. Several of these factors have been incorporated 
in a tool for fracture risk assessment (FRAXTM) (Kanis, Burlet et al. 2008; 
Kanis, Johnell et al. 2008). Extra-skeletal factors can also influence 
fracture risk: for example, falls risk has been shown to be associated with 
fracture risk independent of BMD (Sambrook, Cameron et al. 2007; 
Kayan, Johansson et al. 2009). 
2.2.3 MEDICAL HISTORY 
In addition to the factors mentioned above, several medical conditions or 
history also have an influence on BMD and fracture risk. Similar to the 
factors discussed above, these factors may influence fracture risk through 
their effect on BMD and/or independently. Rheumatoid arthritis has been 
shown to be associated with reduced BMD and increased fracture risk 
(Coulson, Reed et al. 2009). Glucocorticoid treatment in the medium to 
long term has long been known to reduce BMD and also be a risk factor 
for fracture independently of the BMD reduction, probably through effects 
on bone quality (van Staa, Geusens et al. 2005; van Staa 2006; Civitelli 
and Ziambaras 2008). On the other hand, a history of osteoarthritis is 
associated with increased BMD at the spine and hip and reduced fracture 
risk (Liu, Peacock et al. 1997; Blain, Chavassieux et al. 2008; Roux, 
Fechtenbaum et al. 2008). Patients who have been affected by stroke and 
Parkinson's disease have been shown to be at risk of decreasing BMD 
and increased fracture risk (Poole, Reeve et al. 2002; Sato, Metoki et al. 
2003; Watanabe 2004; Bezza, Ouzzif et al. 2008). Some of the increased 
fracture risk associated with these neurological conditions is independent 
of BMD and has been attributed to increased falls risk. Both type 1 and 
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type 2 diabetes mellitus have been shown to be associated with increased 
fracture risk, although type 2 diabetes could be associated with increased 
BMD (Hofbauer, Brueck et al. 2007; Sta Romana and Li-Yu 2007; Rakel, 
Sheehy et al. 2008). The increased fracture risk in type 2 diabetes 
therefore has been thought of as a reflection of bone quality and/or extra-
skeletal factors such as increased falls risk (Hofbauer, Brueck et al. 2007; 
Rakel, Sheehy et al. 2008). Hyperthyroidism has been shown to be 
associated with decreased BMD and increased fracture risk (Linde and 
Friis 1979; Burman 1997; Bassett, O'Shea et al. 2007). There is little 
published on the effect of adult onset hypothyroidism on BMD and fracture 
risk in the literature. However, in a small study, despite treatment with 
thyroxine, young women with congenital hypothyroidism have been shown 
to have decreased BMD compared to controls (Kempers, Vulsma et al. 
2006). 
2.2.4 AREAL PROPERTIES OF BONE 
Issues of bone strength and fracture risk can also be viewed from the 
standpoint of the biomechanical properties of bone. Several 
interdependent concepts have been studied in this respect to elucidate the 
structural risks associated with metabolic bone diseases. Broadly, as a 
biomechanical concept, bone strength can be thought of as a composite of 
the material properties and the areal properties of bone (Rubin and Rubin 
1999). 
Material properties such as stiffness and toughness determine the 
structural quality of the bone. They are determined by the collagen and 
mineral matrix components and the organisation of the micro-architecture. 
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In osteoporosis, the collagen and mineral components are affected 
influencing the material properties of bone (Burr 2002). 
Areal properties such as size, density, architecture and geometry are as 
important as material properties in determining bone strength and risk of 
skeletal failure i.e., fracture. In addition to density, traditionally measured 
as BMD, size and bone geometry may have a role in the higher fracture 
incidence in women (Looker, Beck et al. 2001). In an analysis from the 
Study of Osteoporotic Fractures, femur geometry variables were found to 
be predictive of hip fracture (Kaptoge, Beck et al. 2008). Geometric 
properties of bone can not only have an association with fracture risk, but 
interestingly, may also have a heritable basis. A recent study which 
included geometric properties concluded that both men and women with a 
positive maternal history of osteoporosis may be at greater risk of femur 
neck fracture owing to thinner cortices and lower BMC, which in turn 
results in potentially greater cortical instability at this skeletal site (Looker 
and Beck 2004). 
2.3 ASSESSMENT OF FRACTURE RISK 
In addition to the costs and morbidity associated with osteoporotic 
fractures, there is a recognised association with increased mortality 
(Johnell, Kanis et al. 2004). Assessment of fracture risk has therefore 
become very important for accurate identification of individuals to target 
preventative strategies at both an individual and community level. Hip and 
vertebral fractures are the two most studied osteoporotic fracture types in 
this respect. 
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2.3.1 HIP FRACTURES 
Hip fracture is the most serious outcome of osteoporosis, and this is 
becoming more frequent than before because the world's population is 
ageing and because the frequency of hip fractures is increasing by 1-3% 
per year in most areas of the world (Cummings and Melton 2002). Hip 
fracture is also the costliest to treat. In a recent study of the costs of non-
vertebral fractures, the most costly non-vertebral fracture sites were, in 
decreasing order, hip, femur, and tibia fractures (Ohsfeldt, Borisov et al. 
2006). BMO measurement is the traditionally used to assess hip fracture 
risk, and awareness has improved that an incident hip fracture can be 
predictive of future fracture risk. Despite this, even after hip fracture BMO 
measurement uptake has been found to be poor (Murray, McQuillan et al. 
2005). In addition to BMO, the shape and structure of the proximal femur 
also help to determine how forces act in the hip in a fall and their 
measurement can aid the prediction of hip fracture (Gregory and Aspden 
2008). Therefore, it is possible that methods of assessing hip fracture risk 
other than BMO may improve on uptake of measurement and therefore 
intervention. 
2.3.2 VERTEBRAL FRACTURES 
Vertebral fracture is the most common osteoporotic fracture (Wasnich 
1996). Even as early as the 1980s, an increase in the incidence and 
prevalence of vertebral fractures compared to the 1950s was documented 
(Bengner, Johnell et al. 1988). In addition to the morbidity associated with 
clinical fractures, vertebral fractures in general have also been found to be 
associated with increased mortality. In an analysis from the Study of 
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Osteoporotic Fractures, women with radiographic evidence of vertebral 
fractures were found to have an increased mortality rate, particularly from 
pulmonary disease and cancer (Kado, Browner et al. 1999). However, 
vertebral fracture has been more difficult to define in clinical practice as 
the majority of vertebral fractures are silent (Ziegler, Scheidt-Nave et al. 
1996; McKiernan 2009). While BMD measurement can predict vertebral 
fracture, prevalent vertebral fracture itself has been shown to be predictive 
of further future vertebral fracture (Ross, Genant et al. 1993; Lunt, O'Neill 
et al. 2003), and other osteoporotic fractures (McCloskey, Vasireddy et al. 
2008). In this setting, identification of vertebral fracture itself has become 
important in improving fracture risk assessment and methods such as 
vertebral fracture assessment (VFA) have been studied with this objective 
(McCloskey, Vasireddy et al. 2008; Schousboe, Vokes et al. 2008). Both 
BMD measurement or VFA still require direct scanning or imageing of the 
vertebrae themselves on large devices limiting their accessibility, which 
leaves scope for development of smaller, portable devices or technologies 
to predict vertebral fracture risk by scanning or measuring bone fragility at 
more remote or peripheral sites. 
2.3.3 MODALITIES OF SKELETAL STRENGTH MEASUREMENT 
AND THEIR LIMITATIONS 
Several modalities have been developed to assess skeletal strength with 
varying degrees of success in predicting fracture risk. Some of the main 
ones are discussed below. Each method, based on the underlying 
technology, aims to measure one or more aspects of bone strength 
discussed above. 
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Dual-energy x-ray absorptiometry (DXA): The best documented single 
risk factor for fracture is BMD. DXA is widely regarded as the gold-
standard technology for the measurement of BMD. However, BMD 
measured by DXA is an areal measure expressed in gram/cm2 and not a 
volumetric measure. It does not discriminate between density differences 
caused by volume changes, and those caused by changes in 
mineralization. As such, it does not fully reflect material property changes 
in ageing or osteoporotic bone that contribute to fracture risk (Nielsen 
2000; Burr 2002). It has been found that systematic inaccuracies in DXA 
BMD measurements may exceed +1-20% at typical in vivo lumbar 
vertebral sites. These inaccuracies have been thought to arise principally 
from absorptiometric disparities between the intra- and extraosseous soft 
tissues within the DXA scan region of interest (Bolotin 2001). There are 
also non-technical limitations. DXA is one of the more expensive of current 
technologies in terms of capital costs and running costs. The equipment is 
large and installation needs to meet certain specifications. Because of the 
size, lack of portability is an issue (Miller and Bonnick 1999). 
Quantitative computed tomography (QCT): aCT has been an 
established technique for measuring BMD in the axial spine and peripheral 
skeleton (forearm, tibia). However, aCT availability and utilisation is less 
common than DXA in the UK. Although aCT can determine in three 
dimensions the true volumetric density (mg/cm3) of trabecular or cortical 
bone at any skeletal site, because of the high responsiveness of spinal 
trabecular bone and its importance for vertebral strength, aCT has been 
principally employed to determine trabecular BMD in the vertebral body 
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and assessment of vertebral fracture risk (Guglielmi and Lang 2002). 
Interestingly, in a recent study of postmenopausal women with 
osteoporosis induced by long-term glucocorticoid treatment who were also 
receiving hormone replacement therapy (HRT), BMD of the lumbar spine 
as measured by aCT, but not DXA, was found to be an independent 
predictor of vertebral fractures (Rehman, Lang et al. 2002). Like DXA, 
aCT also has limitations in terms of high capital costs and running costs, 
large size and lack of portability. 
Quantitative ultrasound (QUS): Ultrasound devices routinely measure 
two parameters: broadband ultrasound attenuation (BUA) and speed of 
sound (SOS). Several aus devices are now available for clinical use for 
measuring various parameters at skeletal sites with different contents of 
trabecular and cortical bone. Small size and portability are a major 
attraction of these devices. aus has been shown to detect bone fragility 
and predict fracture risk as well as DXA. There is in fact evidence 
documenting the ability of QUS to predict osteoporotic fracture risk and to 
give further BMD-independent information on bone (Malavolta, Mule et al. 
2004). However, diagnosis of osteoporosis by aus remains contentious, 
but the problems are thought to be due more to the limitations of the 
present T-scores rather than to the technique (Gonnelli and Cepollaro 
2002). In addition, standardization of instruments is still one of the major 
limitations of this technique at present (Malavolta, Mule et al. 2004). 
Other modalities: Several other modalities and devices have been 
developed, most of which aim to measure bone strength or fragility at 
peripheral sites and predict fracture risk. Their main strengths are lower 
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capital costs and running costs, smaller size which means no elaborate 
installation requirements and allowing portability. However, these are 
relatively new on the market, and there is limited information regarding 
their clinical applications, particularly with respect to their performance in 
predicting fracture risk compared to established technologies discussed 
above. Technologies include peripheral instantaneous X-ray imager (PIXI, 
not manufactured at present) (Lawrenson, Nicholls et al. 2006); peripheral 
quantitative computed tomography (paCT) (Sawada, Morishige et al. 
2007); and digital x-ray radiogrammetry (DXR) which is based on 
morphometry of metacarpals. 
2.4 THE METACARPALS AND METACARPAL 
MORPHOMETRY 
The primary function of the forelimb is locomotion in most mammals. The 
forelimb has been successfully adapted in mammals of all sizes for the 
various environments they inhabit: terrestrial, arboreal, aquatic, and 
airborne. In primates, the forelimbs have developed such that speed and 
stamina have been sacrificed for an increased range of movement, which 
in turn has provided increased manual dexterity. This is best developed in 
humans, man being one of only a few mammals who are truly bipedal and 
for whom the forelimb serves almost no locomotive function (Gough-
Palmer, Maclachlan et al. 2008). Another feature not seen in the other 
primates that serves to improve fine manipulation is a more progressive 
and uniform decrease in the size of the hand bones from proximal to 
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distal: although the metacarpals are smaller than those of the chimpanzee, 
the terminal phalanges and apical tufts are comparatively large (Susman 
1979; Gough-Palmer, Maclachlan et al. 2008). 
2.4.1 METACARPAL ANATOMY 
The five metacarpals in each hand are numbered in lateromedial order, 
i.e., the thumb metacarpal is labelled I and the little finger metacarpal is 
labelled V. They are small tubular bones, with a distal head, shaft and 
expanded base. Their rounded heads articulate with the proximal 
phalanges and form the knuckles. At their bases, they articulate with the 
distal carpal row and each other except I and II. The shafts have 
longitudinally concave palmar surfaces, forming hollows for the palmar 
muscles. There is a distal triangular area on the dorsal surface which 
continues proximally as a round ridge. The medial four metacarpals 
diverge somewhat, radiating gently proximodistally. The first metacarpal is 
more anterior and rotated medially on its axis through 90 degrees, 
allowing the thumb to flex medially across the palm and rotated into 
opposition with each finger. The second metacarpal has the longest shaft 
which is prismatic in section and longitudinally curved, convex dorsally and 
concave towards the palm (Soames 1995). Due to similarities in size and 
anatomical appearance, in terms of comparative anatomy, human 
metacarpals \I-V form two sets composed of II-III, and IV-V (Susman 
1979). However, the shafts of both the third and fourth metacarpals are 
similar to the shaft of the second metacarpal (Soames 1995). 
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2.4.2 TUBULAR BONE GEOMETRY AND BIOMECHANICS 
The biomechanical properties of tubular bone can be thought of in terms of 
the properties of a cylindrical object. The ability of a cylinder to resist 
bending and/or torsion is strongly dependent on the distance of the 
material relative to the center of the cylinder. For the same cross sectional 
area, therefore, a cylinder with a larger radius or diameter will demonstrate 
a greater resistance compared to one with a smaller radius/diameter 
(Rubin and Rubin 1999). 
The mechanical strength of a tubular bone in bending can be estimated by 
the area moment of inertia (I) = 1/4 x pi x (R4 - r4) (where R= external 
radius, and r= internal radius). Mechanical strength of bone can therefore 
be considered as dissociated from bone density, since radiological density 
is different from inertia. When the cross-sectional area is constant (C = R2 
- ,-2) in this equation, moment of inertia can be expressed by the equation 
of (I) = 1/4 x pi x (2Cr + C2). Moment of inertia increases with increases of 
the external and internal radii (Chigira 1996). Subtle changes in the cross-
sectional geometry of a bone will therefore contribute significantly to the 
bone's structural properties. In this context, subtle increases in the radii of 
tubular bones achieved through periosteal expansion, may to a certain 
degree compensate for the bone loss and cortical thinning that parallels 
the ageing process, and these changes have therefore been considered 
an adaptation process to ageing (Chigira 1996; Rubin and Rubin 1999). 
As metacarpals are small tubular bones, these biomechanical properties 
apply to them as well. Geometric measures of metacarpals, therefore, can 
offer a way of quantifying mechanical strength and risk of fracture. 
Metacarpal Radiographic Indices In Bone Assessment 34 
2.4.3 TRADITIONAL METACARPAL MORPHOMETRY 
The skeletal system is metabolically active and bone and mineral 
metabolism, mainly through calcium and phosphate levels in the 
extracellular compartment, plays a vital role in maintenance of the normal 
homeostasis. This is regulated both by local hormonal influences (eg. 
Cytokines) and by systemic hormones (eg. Parathyroid hormone) (Mundy 
1999). As the whole skeletal system is in contact with the extracelluar 
compartment, all bones are subject, to greater or lesser extent, to the 
same systemic factors influencing bone strength. Therefore, in theory, 
bone strength measurement at anyone site is also likely to reflect bone 
strength at other sites in general, and hence fracture risk. Peripheral 
bones such as metacarpals are small and easily accessible to 
measurement, and it would be cost-effective and cost saving if 
measurement of bone strength or fracture risk at the metacarpals can be 
shown to predict fracture risk at significant sites such as the hip and spine. 
Barnett and Nordin first proposed morphometric measurements of the 
midshaft of the second metacarpal to diagnose osteoporosis (Barnett and 
Nordin 1960). Measurements were performed on posteroanterior 
radiographs of the hand using a ruler and callipers, or with a graduated 
magnifying glass, of the total and medullary widths (Figure 2.1). The 
measurement originally called the "hand score", and later the "Barnett-
Nordin index" or the metacarpal cortical index (MCI), was expressed as 
the cortical thickness of the radial side plus the cortical thickness of the 
ulnar side divided by the outer diameter of the bone expressed as a ratio 
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(Figure 2.2). In other words, Mel = radial + ulnar cortical thickness/total 
bone width (Nielsen 2001). 
Figure 2.1. Traditional metacarpal morphometry using Vernier 
callipers. 
Figure 2.2. Schematic of the metacarpal mid-shaft on a radiograph 
illustrating the concepts of cortical thickness (CT) and total bone 
width (W) measurement. 
! 
I 
Other metacarpal measures that can also been calculated from the same 
measurements of total and medullary widths or cortical thicknesses 
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(medullary width = total bone width - [ulnar+radial cortical thickness]), are 
the cortical area (CA) and the area ratio. In this measure, the metacarpals 
are regarded as cylindrical, and the cortical area (CA) is calculated as the 
difference between the total area (TA = 1t x (total width/2)2 ), and the 
medullary area (MA = 1t X (medullary width/2) 2), i.e. CA = TA - MA. The 
area ratio is expressed as the ratio of cortical area to the total area, i.e., 
area ratio = CAIT A. Both cortical area and area ratio have been used as 
metacarpal morphometry measures in different studies as measures to 
reflect bone strength (Wishart, Horowitz et al. 1993; Kiel, Hannan et al. 
2001). As the basic measurements used in arriving at MCI and metacarpal 
area ratio are the same, they have been considered interchangeable and 
essentially synonymous (Nielsen 2001). 
The second metacarpal was originally chosen because its variability of 
morphology and length was smaller than that of the other metacarpals 
(Nielsen 2001). In an analysis from the Baltimore Longitudinal Study of 
Ageing, radial cortical thickness of the second metacarpal was found to be 
11-12% greater in men and 10-12% greater in women than ulnar cortical 
thickness in both the left and right hands. In men, radial cortex decreased 
linearly from age 40 to 89. For women, there was a sharp decline in radial 
thickness from age 50 to age 60 (Fox, Kimura et al. 1995). 
Precision and accuracy errors can be an issue with manual techniques. 
One study showed that the intra-observer variability of traditional MCI 
measurement of a single metacarpal approximated 10% of the normal MCI 
(Naor, Oi Segni et al. 1972). High variability among operators has also 
been reported (Nielsen 2001). However, counting six metacarpals (II - IV 
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both sides} in the same x-ray has been shown to reduce precision error to 
compare favourably with the precision of other densitometric techniques 
(Horsman and Simpson 1975). 
Metacarpal bone loss might have little clinical relevance, if not related to 
bone loss at other bone sites, as metacarpal fractures are relatively rare 
and create modest treatment problems. A significant relationship between 
MCI and vertebral biconcavity in osteoporotic patients was reported as 
early as 1971 by Dequeker and colleagues, paving way for further studies 
(Oequeker, Franssens et al. 1971). Metacarpal morphometry was also 
subsequently shown to correlate well with bone density at the forearm and 
vertebral sites (Wishart, Horowitz et al. 1993). 
2.4.4 SEMI-AUTOMATED MORPHOMETRY 
Traditional metacarpal morphometry saw a decline in popularity with the 
development of more sophisticated technologies such as single energy x-
ray absorptiometry (SXA) and subsequently DXA, and more recently 
ultrasound. However, availability of these newer technologies remains 
limited as discussed previously. While metacarpal morphometry has the 
potential to be widely available and incur low costs, the traditional 
radiogrammetry with the measurement of metacarpal cortical bone widths 
using fine needle callipers and hand radiographs is a tedious and time 
consuming task. This is a serious limitation to its widespread use. 
Therefore, efforts have been made since the 1990s to partially or fully 
automate the measurement process. 
A semi-automated method called computed x-ray densitometry using a 
computed densitometric machine (Bonalyser, Teijin Ltd, Tokyo) was 
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reported showing good correlation (0.663) with lumbar BMD measured by 
DXA (Yamamoto, Yuu et al. 1994). In another study the same year, the 
method was shown to have low precision errors (coefficients of variation 
(CV) 0.2-1.2% for metacarpal BMD and 0.4-2.0% for MCI, respectively), 
with a more rapid analysis, within 3 minutes, comparing favourably with 
the previous methods (Matsumoto, Kushida et a!. 1994). An analysis from 
the Hawaii Osteoporosis study reported another technique called 
computer assisted radiographic absorptiometry where metacarpal BMD 
measured from hand radiographs, and quantitative ultrasound (calcaneal 
SUA) were found to be similarly significant predictors of nonspine fracture, 
vertebral fracture, and overall fracture risk (Huang, Ross et al. 1998). 
In Sheffield, an in-house semi-automated technique was also developed in 
the WHO Collaborating Centre. In this method, the hand radiograph was 
placed on a back-lit digitizing tablet and points were placed on the 
metacarpal using a click button cross-wire cursor to measure distances. 
For example, the distance between points A & B were measured by 
clicking on point A and moving the cursor over the digitising tablet to point 
B and clicking a second time. A software program was developed to 
automatically record the distance between the two clicks. During the 
measurement of length of the shaft, the technique included a facility for 
automated computation of the mid-point. At the midpoint of the shaft, the 
cursor was dragged along the outer (periosteal) and inner (endosteal) 
edge of the radial and ulnar cortices of the metacarpal, with multiple 
sampling of coordinates along the cortical edges with the 3 closest 
coordinates on each side of the midline being used to compute metacarpal 
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bone width and cortical thickness. The program algorithm allowed for a set 
sequence of clicks to record several measurements in sequence without 
any further operator input, with the captured measurements being 
automatically fed into an electronic database. MCI of the second 
metacarpal measured with this technique was found to correlate well 
(correlation coefficient 0.62) with MCI measured with the Bonalyzer, and 
also forearm and hip BMD, and a 1 standard deviation reduction in 
measurement was significantly associated with prevalent vertebral fracture 
risk similar to forearm BMD and Bonalyzer, but not as good as hip BMD 
(Dey, McCloskey et al. 2000). However, no studies have been published 
regarding the ability of these semi-automated techniques in predicting 
future fracture risk, i.e., relationship with incident fracture on longitudinal 
follow-up. 
2.4.5 DIGITAL X-RAY RADIOGRAMMETRY (DXR) 
Although semi-automated methods have been developed as above, full 
automation of the measurement process in metacarpal morphometry has 
been attempted aiming to make it simpler, faster and more precise. Fully 
automating the process also makes possible the measurement of multiple 
metacarpals at the same time and multiple sites from each metacarpal, 
with the assumption that a summative measurement is likely to be more 
reflective of bone strength and therefore more predictive of fracture risk 
compared to a single, pOint measurement from a single site of one or more 
metacarpals. 
Thodberg and Rosholm described the development of digital x-ray 
radiogrammetry (DXR) technology, and they identified the main element of 
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this method as the reconstruction of the metacarpals, more specifically the 
metacarpal shafts, in a computerized electronic image using the concept 
of the active shape model (ASM) (Thodberg and Rosholm 2003). 
ASM was described in the mid 1990s as a method of model-based vision 
and image interpretation, specifically aiming at situations where objects of 
the same class are not identical, and where recognizing and locating by 
rigid models is inappropriate: for example, medical applications where the 
shape of organs can vary considerably through time, and between 
individuals. The method involves building models by learning patterns of 
variability from a training set of correctly annotated images, allowing the 
ASMs to deform to fit the data only in ways consistent with the training set 
(Cootes, Taylor et al. 1995). 
Thodberg and Rosholm reported that the standard ASM was unable to 
locate the metacarpal shafts in the direction along the bones. Therefore, 
they reported that ASM was extended with a translation operator, which 
solved the problem (Thodberg and Rosholm 2003). The ASM works by 
detailed edge finding of cortex, and this was achieved by dynamic 
programming to determine average cortical thickness (f), and average 
bone width (W). 
DXR was developed commercially for metacarpal morphometry and 
marketed as the Pronosco X-Posure System (Sectra Pronosco, Denmark). 
The process involves digitising of a single plain radiograph of the hand 
using a high-resolution flat-bed scanner, followed by a completely 
automated image analysis of the digitised image. The system itself 
checked the quality of the scanned images and interrupted the 
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examination in case of inadequate quality. The ASM algorithm was 
adapted to find the diaphysis of the middle three metacarpals in the hand, 
following which regions of interest (ROI) were determined automatically for 
each metacarpal (Jorgensen , Andersen et al. 2000; Thodberg and 
Rosholm 2003). The algorithm placed the three ROls in a coupled fashion 
by sliding them in a partly fixed configuration along the bone shafts to a 
position identified by the minimum combined bone width. The heights of 
the ROls were fixed to 2.0 cm, 1.8 cm, and 1.6 cm for the 2nd, 3rd, and 
4th metacarpal respectively. The analysed images and their ROls were 
displayed on the computer monitor (Figure 2.3). 
Figure 2.3. Computer screen image of DXR regions of interest in the 
2nd to 4th metacarpals. 
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In version 2.0, the BMD was calculated using the cylindrical-tube bone 
model , DXR-BMD = C TT t (1 - t /VV), where c is a constant representing the 
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average mineral mass / unit volume of bone (Rosholm, Hyldstrup et al. 
2001; Thodberg and Rosholm 2003). The constant c was determined so 
that DXR-BMD on the average was equal to that of the mid-distal forearm 
region measured with the Hologic QDR 2000 densitometer (Hologic Inc., 
Bedford, USA) (Bottcher, Pfeil et al. 2006). The Mel of each metacarpal 
was calculated using the traditional principle as described, but using the 
average cortical thickness t, and bone width W, as MCI = 2t / W DXR-MCI 
was calculated as the weighted average of the three metacarpals as 
follows: (MCI2+MCI3+O.5MCI4) I 2.5. The fourth metacarpal was given a 
lower weighting in calculating the average cortical thickness and bone 
width for computing both indices due to a lower precision in measuring the 
fourth metacarpal "and an inferior clinical importance" (Bottcher, Pfeil et al. 
2006). 
Since the Pronosco system was given FDA approval (Version 1 in 1999 
and Version 2.0 in 2000) and was marketed, DXR has been used in 
research resulting in some further published studies. For example, DXR 
has been found to be an effective and sensitive modality for monitoring 
periarticular osteoporosis in hands, which is among the earliest features of 
rheumatoid arthritis, preceding bone erosions (Jensen, Klarlund et al. 
2004; Bottcher, Pfeil et al. 2006). However, there have been only two 
studies published with respect to fracture prediction ability. In an analysis 
from the Study of Osteoporotic Fractures, DXR was shown to predict hip, 
vertebral and wrist fractures in elderly women (Bouxsein, Palermo et al. 
2002). In a subgroup analysis from the third Copenhagen City Heart 
Study, DXR-BMD was found to be predictive of humeral, vertebral, wrist 
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and hip fractures in decreasing order (Bach-Mortensen, Hyldstrup et al. 
2006). 
Interestingly, before the era of DXR, in a study of another automated 
computerized radiogrammetry of the second metacarpal compared with 
forearm and spine absorptiometry, Deriquebourg and colleagues 
commented that radiogrammetry was by no means the best method to 
evaluate bone mass; that its automation did not improve the correlation 
with osteodensitometric values. They felt that radiogrammetry was still of 
interest in mass screening, particularly when other more expensive 
techniques or methods of bone mass measurement are not readily 
available, and that automation just makes it simpler, faster, and more 
precise, rendering its use easier on a larger scale (Derisquebourg, Dubois 
et al. 1994). 
In this context, as discussed above, there is limited information published 
regarding bone strength assessment and, particularly, relevant fracture 
predictive ability for both semi-automated (Dey, McCloskey et al. 2000) 
and fully automated metacarpal morphometry techniques (Bouxsein, 
Palermo et al. 2002; Bach-Mortensen, Hyldstrup et al. 2006) compared to 
the more extensive information published about other established 
modalities such as DXA. There is, therefore, a need for further robust data 
and analyses in this respect to assess whether metacarpal radiographic 
indices could be recommended for use on a wider scale and as 
investigation of choice. 
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3 HYPOTHESIS AND OBJECTIVES 
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The various projects contributing to this dissertation were driven by the 
following hypothesis and objectives. 
3.1 HYPOTHESIS 
Metacarpal radiographic indices: 
• are able to predict future fracture risk 
• are comparable to other established skeletal measures in their 
ability to assess skeletal strength and predict future fractures. 
3.2 OBJECTIVES 
The objectives of the various projects, therefore, were to evaluate: 
• the ability of semi- and fully-automated MCM techniques to predict 
future (incident) hip, vertebral and other fractures. 
• the fracture risk prediction of MCM in comparison to established 
techniques such as DXA. 
• the correlation between various MCM measures, and between 
MCM measures and DXA measurements at other sites. 
• the interaction between MCM and a history medical risk factors. 
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4 DXR IN THE PREDICTION OF HIP FRACTURES 
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4.1 ABSTRACT 
Introduction: Hip fracture is the most expensive osteoporotic fracture type 
to manage. A combination of assessments of skeletal strength and extra-
skeletal risk factors optimises the identification of future fracture risk. While 
hip bone mineral density (BMO) remains the reference standard, other 
more widely applicable skeletal measures may be of value. In this study 
the ability of metacarpal BMD and metacarpal cortical index (MCI) 
measured by digital x-ray radiogrammetry (DXR) were compared to that of 
hip BMD to predict incident hip fractures. 
Methods: A nested case-control design was used within the context of a 
large prospective study cohort comprising 5212 women aged 75 years or 
older (mean 80 years, range 75-100) enrolled to a double-blind placebo-
controlled study of the bisphosphonate, clodronate (Bonefos®). This 
analysis included 153 women who sustained incident hip fractures and 
532 randomly selected controls who remained free of hip fracture during a 
median follow-up of 4 years. Baseline BMO at the total hip and distal 
forearm were measured by OXA (Hologic QDR4500 and Osteometer 
OTX200 respectively). Bilateral hand radiographs obtained at baseline 
were analysed using DXR to produce automated measures of metacarpal 
BMD (DXR-BMD) and OXR-MCI. 
Results: The hip fracture group had significantly lower hip BMO, forearm 
BMD and DXR indices at baseline than controls. There was no significant 
difference between the fracture and control groups with respect to 
clodronate treatment. In univariate logistic regression analysis, the odds 
ratios (OR, 95%CI) for hip fracture per 1 SO decrease in OXR-BMD and 
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DXR-MCI of 1.79 (1.47-2.19, P<0.001) and 1.72 (1.41-2.11, P<0.001) 
respectively were similar to that of forearm BMD of 1.90 (1.55-2.34, 
P<0.001) while a similar decrease in total hip BMD demonstrated a larger 
gradient of risk of 2.33 (1.87-2.90, P<0.001). DXR indices remained 
significant predictors of hip fracture following adjustment for clinical 
predictors (age and body weight) (1.46, 1.17-1.81, and 1.43, 1.15-1.76, 
respectively) but were not independent of forearm BMD or hip BMD. 
Following adjustment for the clinical variables, the ORs for the DXR 
indices remained comparable to that of forearm BMD (1.51, 1.19-1.91) but 
was lower than that for total hip BMD (1.98, 1.56-2.50). 
Conclusions: In this study DXR indices were found to be significant 
predictors of hip fracture independently of other extra-skeletal clinical risk 
factors. Hip BMD remained the strongest predictor of hip fracture. In the 
absence of access to DXA, metacarpal indices may prove useful skeletal 
measures for fracture prediction to include in the risk assessment of 
individuals. 
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4.2 INTRODUCTION 
Osteoporosis and fragility fractures cause significant morbidity, and the 
principal underlying skeletal cause is reduced BMD. However, extra-
skeletal risk factors also predispose to fracture occurrence. Therefore a 
combination of assessments of skeletal strength and extra-skeletal risk 
factors optimises the identification of future fracture risk. 
Hip fracture is not only associated with significant morbidity but also 
mortality (Browner, Pressman et al. 1996; Johnell, Kanis et al. 2004). 
While single measures of skeletal strength such as hip BMD by DXA have 
been shown to predict site specific and remote fracture risk (Marshall, 
Johnell et al. 1996), and remain the reference standard for skeletal 
strength assessment, the scanner required to perform the measurements 
requires significant space and other resources to operate. It is also unclear 
if combined measures of skeletal strength are of more value in fracture 
prediction than single measurements. Other methods of skeletal strength 
assessment incorporating composite measures may be of value and more 
widely applicable in predicting fracture risk (Gluer, Wu et al. 1993; Gatti, 
Sartori et al. 2001). 
Metacarpal morphometry was described in 1960 as a method of skeletal 
strength assessment from hand radiographs, but did not gain mainstream 
recognition as the traditional manual technique was a tedious and time 
consuming process (Barnett and Nordin 1960; Horsman and Simpson 
1975). Semi-automated MCM techniques have since been described 
showing ability in predicting fracture risk (Dey, McCloskey et al. 2000). 
More recently digital x-ray radiogrammetry (DXR) has been developed 
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where these measurements have been fully computerised and automated, 
significantly reducing both the time and effort involved (Jorgensen, 
Andersen et al. 2000). 
DXR has been shown to be comparable to other peripheral measures 
such as quantitative ultrasound in the detection of osteoporosis (Boonen, 
Nijs et al. 2005). However, the ability of DXR to predict fracture risk itself 
has not been widely reported previously. The aim of the current study was 
therefore to determine the ability of DXR indices to predict hip fracture risk, 
and to compare their performance to that of DXA measurements. 
4.3 METHODS 
4.3.1 SUBJECTS 
MRC Hip fracture Prevention Study (HIPS): HIPS was a single-centre 
study based at Sheffield, UK between 1996 and 2002. The aim was to 
identify risk factors for hip fracture in elderly caucasian women combined 
with a randomised placebo-controlled trial of oral clodronate (Bonefos®) 
for fracture prevention. 
A total of 5212 community dwelling women aged 75 years or over were 
recruited to the study. Following baseline assessments of risk factors, the 
women were randomised to receive oral clodronate 800mg or an identical 
placebo for 3 years and were followed for up to a further 2 years. 
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4.3.2 DESIGN 
This particular analysis was designed as a nested case-control study 
within the HIPS cohort. The group had been pre-selected for the purpose 
of several analyses and included 153 women who sustained low-trauma 
hip fracture along with 534 randomly selected controls who did not sustain 
hip fracture during the study period. 
4.3.3 MEASUREMENTS 
Data including medical and fracture history were collected at enrolment 
from all subjects. Height and weight were recorded and baseline hand 
radiographs were performed. 
4.3.3.1DXA at baseline: 
Subjects had hip and forearm BMD by DXA on a Hologic QDR4500 
(Hologic Inc., Bedford, USA) and an Osteometer DTX200 (Osteometer 
Meditech Inc., Hawthorne, USA) respectively. 
4.3.3.2DXR indices: 
The Sectra/Pronosco X-posure System ™ (Sectra, Denmark), Version 2.0, 
was used to obtain measurements from hand radiographs taken at 
baseline. These comprised DXR-MCI and DXR-BMD as described below: 
DXR-MCI: The cortical index (CI) of a tubular bone is calculated as: CI = 
2t I W, where t = cortical thickness and W = bone width of said bone. MCI 
is calculated as a weighted average of the Cl's of the middle 3 
metacarpals: Mel = (C/2+C/3+O.5C/4) /2.5 (Bouxsein, Palermo et al. 2002; 
Thodberg and Rosholm 2003). 
Metacarpal Radiographic Indices In Bone Assessment 52 
DXR-BMD: This is computed using the formula for tubular bones as: DXR-
BMD = C JT t (1 - t IW), where C is a constant representing the average 
mineral mass / unit volume of bone (Rosholm, Hyldstrup et al. 2001). 
Both measurements were obtained from the non-dominant side with 
automated output. 
4.3.3.3Fracture data 
All subjects were followed up at 6 monthly intervals by study nurses. As 
part of the follow-up data collection, all incident fracture data were also 
collected. All reported fractures were independently confirmed and 
classified by verifying the x-ray or x-ray report. Hip fractures were further 
classified according to x-ray or x-ray report as 'femoral neck' or 
'trochanteric' fractures. 
4.3.3.4Statistics 
Data were collected on databases derived from the Microsoft Office 
Access database software. These were subsequently tranferred to, and 
processed and analysed in the SPSS Version 11.x statistical package. 
Baseline characteristics were studied using ANOVA. Gradients of risk for 
incident hip fracture for 1 standard deviation decrease in measurement of 
skeletal strength were studied using univariate and multivariate 
regression. Correlations between the various skeletal measures were 
studied using Pearson corrleation coefficients and measures of agreement 
by the kappa coefficient. A P value of <0.05 was considered statistically 
significant. 
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4.4 RESULTS 
The median duration of follow-up during the study was 4 years. The 
proportion of subjects who received clodronate was similar between the 
hip fracture group and control group (46% vs. 50%, not significant). 
4.4.1 BASELINE CHARACTERISTICS (TABLE 4.1) 
Women who had incident hip fractures were on average 1.6 years older at 
baseline than those who did not (P<0.001). They also had lower body 
weight and body mass index (8MI, P<0.001), and although there was an 
approximately 1 cm difference in mean height, this was not significantly 
different. All mean skeletal strength measures including DXA and DXR 
indices were significantly lower in the hip fracture group (P<0.001), except 
mean metacarpal bone width which was not significantly different. 
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Table 4.1. Comparison of baseline characteristics (mean ± SO). 
Fracture Control group P 
group (n=534) (ANOVA) 
(n=153) 
Age (years) 80.9±4.4 79.3±3.8 <0.001 
Height (cm) 155.1±6.0 156.2±6.5 0.069 
Weight (kg) 59.3±9.7 65.9±12.5 <0.001 
BMI (kgm-2) 24.6±3.9 27.0±4.7 <0.001 
Total hip BMD (gcm-£) 0.658±0.127 0.766±0.142 <0.001 
Femoral neck BMD (gcm-2) 0.564±0.093 0.659±0.129 <0.001 
Trochanteric BMD (gcm-2) 0.500±0.110 0.587±0.123 <0.001 
Ward's area BMD (gcm-£) 0.360±0.108 OA62±0.140 <0.001 
Forearm BMD (gcm-2) 0.302±0.070 0.346±0.076 <0.001 
DXR BMD (gcm-2) OA08±0.053 OA39±0.055 <0.001 
DXR MCI 0.296±0.050 O. 322±0. 051 <0.001 
Cortical thickness (cm) 0.121±0.019 0.132±0.020 <0.001 
Bone Width (MC 2-4, cm) 0.819±0.044 0.822±0.049 0.595 
Clodronate treated (%) 70 (46) 269 (50) 0.359* 
*Chl-square test. 
4.4.2 DISTRIBUTION OF FRACTURES BASED ON SKELETAL 
STRENGTH 
Data for all 4 skeletal measures were divided into quartiles of strength 
(1 = lowest and 4=highest) and fracture distribution in each quartile was 
studied. For all measures, the highest incidence of fracture was in quartile 
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1 and the lowest incidence in quartile 4. The steepest distribution was in 
total hip BMD with less steep but similar distributions among forearm BMD 
and the 2 DXR indices (Figure 4.1). 
Figure 4.1 . Proportion of hip fractures in each quartile of 
measurements of total hip BMD, forearm BMD, DXR-BMD and DXR-
MCI in the whole study group (n=687). (Quartile 1 =Iowest and quartile 
2 3 4 
Quartiles of measurement 
.Total Hip BMD 
• Forearm BMD 
o DXR-BMD 
o DXR-MCI II 
4.4.3 GRADIENTS OF RISK FOR HIP FRACTURE FOR 1 SO 
DECREASE IN MEASUREMENTS (TABLE 4.2 & Fig 4.2A) 
Total hip and forearm DXA measurements as well as DXR-BMD and DXR-
Mel measurements were converted to standard deviation units against the 
mean values of each measure for the whole cohort (Z scores). In 
univariate analysis of Z scores using logistic regression , all 4 skeletal 
measures were significant predictors of hip fracture expressed as odds 
ratios (OR's) and 95% confidence intervals. After adjusting for age and 
body weight in a forward-conditional logistic regression model, all the 
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measures remained significant predictors of hip fracture. Total hip BMD 
(and its subregions) had the highest odds ratios with both the DXR indices 
having OR's similar to that of forearm BMD (Table 4.2 & Figure 4.2A). 
Table 4.2. Unadjusted and adjusted (for age and weight) odds ratios 
(95% confidence intervals) for all hip fractures (n=153) for a 1 SO 
decrease in measurements of bone strength (P~O.001 for all). 
Unadjusted OR Adjusted OR* 
Total hip BMD 2.33 (1.87-2.90) 1.98 (1.56-2.50) 
Femoral neck BMD 2.88 (2.22-3.73) 2.44 (1.85-3.21) 
Trochanteric BMD 2.17 (1.75-2.69) 1.83 (1.46-2.30) 
Ward's area BMD 2.62 (2.05-3.36) 2.24 (1.74-2.89) 
Forearm BMD 1.90 (1.55-2.34) 1 .51 (1.19-1.91) 
DXR-BMD 1.79 (1.47-2.19) 1.46 (1 .17-1 .81 ) 
DXR-MCI 1.72 (1.41-2.11) 1.43 (1.15-1.76) 
. . 
*Forward-condltlonalloglstlc regression . 
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Figure 4.2A. Adjusted OR's (point estimates) and 95% CI (high and 
low lines) from Table 4.2 plotted as a graph. 
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4.4.4 FEMORAL NECK VS. TROCHANTERIC FRACTURES 
The hip fracture group was subclassified into femoral neck and 
trochanteric fracture subgroups (baseline characteristics, Table 4.3). One 
patient was excluded as the type of fracture was not classified. The 
trochanteric fracture group had significantly lower DXR-BMD (P=O.039) 
and mean metacarpal cortical thickness (P=O.046), but there was no 
difference in mean metacarpal bone width (P=O.84). The trochanteric 
fracture subgroup also showed non-significant trends towards greater age, 
lower mean body weight, BMI, total hip and forearm BMD, and DXR-MCI. 
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Table 4.3. Comparison of femoral neck and trochanteric fracture sub-
groups (mean ± standard deviation). 
Femoral neck Trochanteric P 
(n=106) (n=46) (AN OVA) 
Age (years) 80.6±4.3 81.7±4.6 0.185 
Height (cm) 155.0±5.9 155.2±6.1 0.871 
Weight (kg) 59.6±10.0 58.2±8.9 0.424 
BMI (kgm-z) 24.7±4.0 24.2±3.6 0.464 
Total hip BMD (gcm-2) 0.666±0.136 0.638±0.102 0.225 
Femoral neck BMD (gcm-2) 0.567±0.099 0.556±0.077 0.489 
Trochanteric BMD (gcm-Z) 0.510±0.117 0.477±0.090 0.091 
Ward's area BMD (gcm-') 0.364±0.117 0.350±0.087 0.478 
Forearm BMD (gcm-2) 0.307±0.067 0.289±0.076 0.166 
DXR-BMD (gcm-Z) 0.414±0.051 0.395±0.055 0.039 
DXR-MCI 0.301±0.049 0.284±0.050 0.053 
Cortical thickness (cm) 0.123±0.019 0.116±0.020 0.046 
Bone Width (MC 2-4, cm) 0.819±0.042 O. 820±0. 049 0.840 
4.4.5 GRADIENTS OF RISK OF FEMORAL NECK AND 
TROCHANTERIC FRACTURE FOR 1 SD DECREASE IN 
MEASUREMENTS (TABLE 4.4): 
After adjustment for age and body weight in a forward-conditional logistic 
regression model, all 4 skeletal measures were significantly predictive of 
both femoral neck and trochanteric hip fracture expressed as OR's (95% 
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CI). Similar to the whole hip fracture group, hip BMD and its subregions 
had the highest OR's with forearm BMD having OR's similar to the two 
OXR indices for both fracture subtypes. The point values for OR's were 
also somewhat higher for the trochanteric fracture subgroup for all 4 
measures. 
Table 4.4. Odds ratios (95% confidence intervals), adjusted for age 
and weight, for femoral neck and trochanteric fractures for a 1 SO 
decrease in measurements of bone strength (forward-conditional 
logistic regression, all P<O.05). 
Femoral neck Trochanteric 
(n=106) (n=46) 
Total hip BMO 1.83 (1.42-2.37) 2.45 (1.72-3.48) 
Femoral neck BMO 2.32 (1.71-3.15) 2.95 (1.92-4.53) 
Trochanteric BMO 1.67 (1.31-2.13) 2.08 (1.47-2.95) 
Ward's area BMO 2.13 (1.61-2.81) 2.38 (1.58-3.59) 
Forearm BMO 1.47 (1.12-1.92) 2.07 (1.44-2.98) 
OXR-BMO 1.36 (1.07-1.73) 2.02 (1.40-2.93) 
OXR-MCI 1.34 (1.06-1.70) 1.97 (1.36-2.85) 
4.4.6 MULTIVARIATE ANALYSIS 
All variables that were significantly different at baseline between the hip 
fracture group and the controls were entered into a multivariate forward-
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conditional logistic regression model to determine independent predictors 
of hip fracture. In this model, age, weight and total hip BMO were 
independently associated with fracture risk (Table 4.5). 
Table 4.5. Independent predictors of hip fracture. Mutivariate 
analysis. 
Odds Ratio, 95% CI 
Age (yrs) 1 .06, 1.01-1.11 * 
Weight (kg) 0.98, 0.96-0.995* 
Total hip BMO (1 SO decrease) 1.98, 1.56-2.50* 
Forearm BMO (1 SO decrease) 0.92, 0.66-1.29 
OXR-BMO (1 SO decrease) 1.16, 0.70-1.91 
OXR-MCI (1 SO decrease) 0.99, 0.62-1.60 
. . 
*Forward-condltlonalloglstlc regression, P<0.02 . 
Amongst the skeletal measures only, to identify if any of the peripheral 
measures predicted fracture risk independent of total hip BMO, each of the 
measures was put through a forward-conditional regression model with 
total hip BMO. After adjusting for total hip BMO in the regression model, 
forearm BMO as well as both the OXR indices were no longer significantly 
associated with fracture risk (Table 4.6). 
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Table 4.6. Multivariate analysis: gradients of fracture risk for 1 SO 
decrease in measurement adjusted for total hip BMO (odds ratios, 
95% CI). 
Odds Ratio, 95% CI P 
Forearm BMD 1.06,0.77-1.45 0.736 
DXR-BMD 1.28,0.78-2.10 0.324 
DXR-MCI 0.93, 0.58-1.49 0.771 
4.4.7 ASSOCIATION MEASURES BETWEEN THE DXA AND DXR 
INDICES 
Correlation Coefficients: 
Pearson correlations were calculated between hip BMD and the other 3 
skeletal measures and are summarised in Table 4.7. Total hip BMD had 
slightly better correlation with forearm BMD and DXR indices compared to 
femoral neck BMD. 
Table 4.7. Correlation (Pearson coefficients) between the various 
skeletal measures (all P<O.01). 
Forearm BMD DXR-BMD DXR-MCI 
Total hip BMD 0.67 0.57 0.54 
Femoral neck BMD 0.59 0.50 0.46 
Forearm BMD 
-
0.71 0.68 
DXR-BMD 
-
- 0.90 
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Scatter Plots: 
Using the SPSS software, scatter plots with fit lines were constructed to 
study the associations between the various skeletal measures (Figures 
4.2-4.4). T scores were computed from BMD data using previously 
published normative data for peak bone mass in a young adult for DXR-
BMD (Black, Palermo et al. 2001), and the manufacturer's normative data 
for DXA. Using the traditional definition of osteoporosis as T score ::; - 2.5, 
reference lines were created on the scatter plots. 
Figure 4.2. Scatter plot correlating total hip DXA T - scores and 
forearm DXA T -scores. 
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Figure 4.3. Scatter plot correlating total hip DXA T scores and DXR-
BMD T scores. 
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Figure 4.4. Scatter plot correlating forearm BMD and DXR-BMD. 
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Kappa Coefficients: 
Data from the reference lines were used to compute measures of 
agreement (kappa coefficients) on the diagnosis of osteoporosis (Table 
4.8) . Compared to femoral neck BMD, total hip BMD had slightly stronger 
agreement with forearm BMD and DXR-BMD. 
Table 4.8. Measures of agreement (kappa coefficient) between DXA 
and DXR-BMD (all P<O.05)*. 
Forearm BMD DXR-BMD 
T. hip BMD 0.39 ' 0.40L 
Femoral neck BMD 0.38" 0.364 
Forearm BMD - 0.450 
... 
*Deftnltlon of osteoporosIs based on flt- and reference lines of scatter plots as 
below: 
11. hip T score -2.5 = Forearm T score - 3.3 
2T. hip T score - 2.5 = DXR-BMD T score -3.45 
3Femoral neck T score -2.5 = Forearm T score -3.05. 
4Femoral Neck T score -2.5 = DXR-BMD T score -3.25. 
5Forearm T score - 2.5 = DXR-BMD T score -2.85. 
4.4.8 ROC CURVES AND SENSITIVITY AND SPECIFICITY 
COMPARISONS 
Using the WHO definition of osteoporosis as T score $ -2.5 at the total hip 
by DXA as reference, Receiver Operating Characteristic (ROC) curves 
were produced for forearm DXA and the DXR indices (Figure 4.5). 
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Figure 4.5. ROC curves of the skeletal measures with total hip BMD 
as reference for the diagnosis of osteoporosis. 
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The 'area under the curve' calculations were similar and statistically 
significant (P<O.001) for all the three measures (Table 4.9) . Using 
coordinates of the curve, sensitivity and specificity of forearm BMD and 
DXR-BMD T scores were calculated at various thresholds including 
thresholds that were used in computing the kappa coefficients. These 
were broad ly similar although forearm BMD seemed to have slightly higher 
specificity than DXR-BMD at similar thresholds (Table 4.10). 
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Table 4.9. Area under the curve for skeletal measures in diagnosis of 
osteoporosis with total hip BMD as reference (T score~ -2.5). 
Area under the curve±SE (all P<0.001) 
Forearm BMD 0.82±0.02 
DXR-BMD 0.78±0.02 
DXR-MCI 0.76±0.02 
Table 4.10. Sensitivity and specificity by T score cut off points of 
skeletal measures in diagnosis of osteoporosis with total hip T score 
as reference. 
T score Sensitivity (%) Specificity (%) 
Forearm BMD -2.5 90.7 51.2 
-3.00 82.1 69.7 
-3.3 66.7 77.4 
DXR-BMD -2.5 91.4 41.9 
-3.00 79.6 60.2 
-3.45 71 76.1 
4.5 DISCUSSION 
In this study the ability of DXR indices to predict future hip fracture was 
compared to that of DXA measures. DXR indices were significantly lower 
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at baseline in the hip fracture group compared to controls independent of 
age and body weight. While total hip BMO remained the strongest 
predictor of hip fracture, the OR's for 1 SO decrease in measurement of 
the OXR indices were significant and similar to that of forearm SMD. The 
correlations between hip SMO and the OXR indices were similar to that of 
hip and forearm SMD. With hip SMO as reference standard, forearm BMO 
and OXR-BMD had similar sensitivity and specificity in diagnosing 
osteoporosis. 
4.5.1 BASELINE CHARACTERISTICS 
Similar to findings in previous studies, in this study incident hip fracture 
was associated with greater age (lain Elabdien, Olerud et al. 1984; 
Bouxsein, Palermo et al. 2002) and low body weight or 8MI (Johnell, 
Gu"berg et al. 1995; Bouxsein, Palermo et al. 2002). The differences 
between the fracture and control groups in the OXR indices seem to be a 
reflection of significantly lower mean cortical thickness of the scanned 
metacarpals rather than the mean bone width which was similar in both 
groups. This may represent endosteal bone resorption reflecting true loss 
of bone mass while a change in bone width may reflect a change in 
geometry-related bone strength. Although Bouxsein and colleagues 
reported on DXR indices, no data or comment were included in their report 
regarding measured cortical thickness and bone width. 
The trends for greater age, lower body weight and lower DXA measures 
noted in the trochanteric fracture group compared to femoral neck fracture 
group were reported previously (Mautalen, Vega et al. 1996; Stewart, 
Porter et al. 1999), although these were not significant in our study. 
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Bouxsein and colleagues reported on the hip fracture subtypes, but no 
data on age or body weight or indeed mean values of DXA or DXR were 
included in the subtype analysis. While DXA measures did not distinguish 
between the two subtypes in the current study, DXR-BMD was significantly 
lower at baseline in the trochanteric subgroup. This is in keeping with 
previous reports that peripheral BMD measures were lower at baseline in 
trochanteric fractures compared to femoral neck fractures (Mautalen, Vega 
et al. 1996; Stewart, Porter et al. 1999). In fact, women sustaining 
trochanteric fractures were reported to have lower bone mass at the hip by 
DXA, distal radius by peripheral aCT, and tibia by aus, while those 
sustaining femoral neck fractures had low BMD primarily at the hip 
suggesting more generalised skeletal loss in women sustaining 
trochanteric fractures (Augat, Fan et al. 1998). 
4.5.2 PREDICTING FUTURE HIP FRACTURE 
Total hip BMD and its subregions remained the strongest predictors of hip 
fracture in this study with unadjusted OR's of 2.33 for total hip BMD and 
2.88 for femoral neck BMD. This site specificity is in keeping with the 
report by Bouxsein and colleagues, where femoral neck BMD was the 
strongest predictor of hip fracture with an age-adjusted relative hazard 
(RH) of 3.0 for 1 SO decrease in BMO, (Bouxsein, Palermo et al. 2002), 
and also the meta-analysis by Marshall and colleagues, where hip BMO 
measurement was found to be the strongest predictor of hip fracture with a 
relative risk of 2.6 for 1 SO decrease in BMD (Marshall, Johnell et al. 
1996). 
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In the current study, hip and forearm DXA, as well as the DXR-BMD & 
DXR-MCI were significant predictors of both trochanteric and femoral neck 
fractures although all were better predictors of trochanteric fracture (OR's 
2.45, 2.07, 2.02 and 1.97 respectively) than femoral neck fractures (OR's 
1.83, 1.47, 1.36 and 1.34 respectively). However, Bouxsein and 
colleagues reported that while forearm BMD, and DXR indices predicted 
trochanteric fractures significantly (RH's 1.9-2.3), they did not predict 
femoral neck fractures (1.0-1.3, not significant) (Bouxsein, Palermo et al. 
2002). This may be because the mean age of their hip fracture cohort was 
75.5 years, while our cohort was older with a mean age of 80.9 years and 
consequently likely to be more osteoporotic in general. As no mean values 
for the skeletal measures were reported for the fracture subtypes by 
Bouxsein and colleagues, this can only be speculated. Interestingly, in the 
only other study published of DXR-BMD in predicting osteoporotic 
fractures, Bach-Mortensen and colleagues found that the trend in DXR-
BMD decrease with hip fracture did not reach statistical Significance 
(P=0.052), but this could have been because of the relatively small 
number of incident fractures in their study (total of 245 women who 
suffered fracture) (Bach-Mortensen, Hyldstrup et al. 2006). 
4.5.3 DIAGNOSIS OF OSTEOPOROSIS 
The correlations between total hip BMD and DXR indices were significant 
in this study although the magnitude was less than 0.6. Femoral neck 
BMD had weaker correlation with DXR-BMD similar to those reported 
previously by Bouxsein and colleagues (0.5 in both studies). The 
correlation between forearm BMD and DXR indices was somewhat better 
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around 0.7, and this was similar to that reported by Bouxsein and 
colleagues (0.68 with distal radius BMD, and 0.75 with proximal radius 
BMD). In fact, in the present study forearm BMD correlated better with 
DXR-BMD than with total hip BMD (0.71 vs. 0.67 respectively). The 
strongest correlation in our study was between DXR-BMD and DXR-MCI 
(0.9), comparing well with that reported by Bouxsein and colleagues 
(0.87). This was as expected as both measures are computed using the 
same measurements captured on radiogrammetry. 
Recently, a threshold T score of -1.53 by DXR-BMD (using an earlier 
version 1 of Pronosco X-posure system) was reported as having a 
sensitivity of 79.6% and specificity of 76.3% in diagnosing osteopenia 
using total hip BMD as reference standard (T score < -1) (Ward, Cotton et 
al. 2003), but no specific values were reported for the sensitivity and 
specificity in diagnosing osteoporosis itself. In our study DXR indices had 
similar sensitivity and specificity in diagnosing osteoporosis to that of 
forearm BMD at various thresholds with total hip BMD as reference. While 
the measures of agreement with total hip BMD were only moderate for the 
various skeletal measures (kappa <0.5), the area under the curve (AUC) 
for DXR-BMD was 0.78 which was comparable to 0.84 reported by Ward 
and colleagues with the earlier Version 1. 
4.5.4 POTENTIAL LIMITATIONS 
The present study was designed as a nested case-control study in the 
context of a larger prospective cohort study. The smaller group was 
selected to perform several analyses in addition to the primary objectives 
in a cost effective manner. The relatively small number of fractures studied 
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meant that while the point estimates of the various OR's reached statistical 
significance, the confidence intervals were relatively wide. Although 
analysing the whole cohort would have possibly provided a more robust 
database and tighter confidence intervals for the OR's, it is unlikely to 
have significantly added to the overall findings, as the findings were 
largely in keeping with those reported by Bouxsein and colleagues who 
reported on a similar nested case-control group chosen from a much 
larger cohort of over 9000 subjects. 
Our study was also a setting for a placebo controlled trial of clodronate 
which could be a potential confounder. However, at baseline a similar 
proportion of the hip fracture and control group had received clodronate 
with no statistically significant difference. It is, therefore, likely that the 
findings are generalisable in the context of hip fracture prediction. 
The ability of DXR indices in predicting hip fracture risk in the long term is 
not known. In our study, the median duration of follow-up was 4 years 
comparable to that reported by Bouxsein et al (4-5 years). However, single 
peripheral measurements may predict long term risk: for example, forearm 
BMD was reported to predict fractures over 25 years (Duppe, Gardsell et 
al. 1997). It is possible that DXR indices may also have such predictive 
ability as they seem to be comparable to forearm BMD over the shorter 
follow up in this study. 
In this study, a later version of the Pronosco X-posure system (Version 
2.0) was used where the DXR indices were computed using 
measurements from the second to fourth metacarpals only. The initial 
version 1 employed measurements from the metacarpals, radius and ulna 
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for computing DXR-BMD (Jorgensen, Andersen et al. 2000; Bouxsein, 
Palermo et al. 2002), raising the possibility that measurements may not be 
comparable between the two versions. However, Black and colleagues 
compared the association with fracture risk for DXR-BMD computed from 
metacarpals to that computed from metacarpals, radius and ulna and 
found them to be similar (Black, Palermo et al. 2001). This suggests that 
the findings from the present study are comparable to measurements in 
previous studies using the initial version as well. 
4.6 CONCLUSIONS 
In this analysis, DXR indices were found to predict future hip fracture risk. 
While hip BMD remains the strongest predictor of hip fracture, DXR 
indices are at least as able as forearm BMD in predicting fracture risk and 
in diagnosing osteoporosis. DXR may have a significant role in the more 
widespread provision of osteoporosis diagnostic services, either as a 
stand-alone assessment of risk where DXA facilities are not available, or 
as a screening tool to target axial measurements of BMD. 
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5.1 ABSTRACT 
Introduction: Vertebral fracture is the commonest osteoporotic fracture 
type. It is not yet clear whether combined measures of skeletal strength 
are of more value in the prediction of fracture risk than a single 
measurement alone. The aim of this study was to determine the ability of 
two new simple measurements derived from hand radiographs to predict 
future vertebral fractures, and to compare their performance with that of 
DXA measurements at the spine and hip in women with osteoporosis. 
Methods: This analysis was performed on data from the Vertebral 
Osteoporosis Trial (VOT). 538 women fulfilling the WHO criteria for 
osteoporosis (spine or hip T-score <-2.5) and/or with at least one prevalent 
vertebral fracture were recruited to a 3-year double-blind, controlled study. 
The women received either c1odronate 800mg daily by mouth (Bonefos®) 
or an identical placebo and all patients received a calcium supplement of 
500mg daily. Bone density (BMD) was measured at the spine and hip by 
DXA at baseline. Prevalent and incident vertebral fractures were identified 
by morphometric evaluation of lateral spine radiographs obtained at 
baseline and annually thereafter. Hand radiographs obtained at baseline 
were analysed using the Pronosco X-posure system ™ to derive DXR-
BMD and metacarpal cortical index (DXR-MCI). 
Results: 90 women (17%) experienced one or more incident vertebral 
fractures during the study. At baseline, these women were significantly 
older and had significantly lower mean values of BMD at the lumbar spine, 
hip, DXR-BMD and DXR-MCI (P :s; 0.001 for all). In univariate analysis, the 
gradients of risk per 1 SD decrease (Odds Ratio, 95%CI) for incident 
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vertebral fractures were similar for lumbar spine BMD and DXR-MCI (1.82, 
1.37-2.43 and 1.81, 1.37-2.39 respectively), and were slightly higher than 
that for DXR-BMD and total hip BMD (1.56, 1.23-1.96, and 1.46, 1.16-1.96 
respectively). In a mUltivariate forward conditional regression model, the 
baseline presence of vertebral fracture, spine BMD and DXR-MCI were all 
significant independent predictors of future vertebral fracture with ORs of 
6.84,3.66-12.78 for prevalent vertebral fracture; 1.56, 1.17-2.07 for lumbar 
spine BMD; and 1.47, 1.04-2.07 for DXR-MCI. 
Conclusions: In this study, DXR-BMD and DXR-MCI were found to be 
predictors of future vertebral fracture risk in women with osteoporosis that 
are similar in performance to lumbar spine or hip BMD. Moreover, DXR-
MCI may capture a component of risk for incident vertebral fractures that is 
not accounted for by other measures of BMD. DXR measures may have 
wide applicability in the management of osteoporosis since hand 
radiographs are relatively inexpensive and involve low doses of radiation. 
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5.2 INTRODUCTION 
Vertebral fracture is the commonest type of osteoporotic fracture (Wasnich 
1996). It has been found to be not only associated with increased 
morbidity but also mortality (Kado, Browner et al. 1999). However, the 
majority of vertebral fractures are silent, and this can pose problems at the 
clinical practice level in identifying those at risk (Ziegler, Scheidt-Nave et 
al. 1996; McKiernan 2009). 
Reduced bone mass measured as bone mineral density (BMO) by dual-
energy x-ray absorptiometry (OXA) has been shown to be an independent 
risk factor for fracture in several studies (Marshall, Johnell et al. 1996). 
OXA is currently the most commonly used measure of bone mass and it 
has been shown that single BMO measurements at a particular skeletal 
site is predictive of over-all fracture risk (relative risk RR 1.5 per 1 standard 
deviation (SO) decrease in measurement) with optimal prediction for the 
site of measurement (RR 2-3 per 1 SO decrease) (Marshall, Johnell et al. 
1996). Cadaveric studies demonstrate that BMD as measured by OXA 
determines only 50-80% of skeletal strength at identical or closely related 
sites, and only 20-35% at distant sites, supporting the concept that BMO is 
site specific to a large extent (Cheng, Lowet et al. 1998; Eckstein, 
Lochmuller et al. 2002). Other characteristics of the bone may determine 
a proportion of skeletal strength, as is shown by some differences in 
fracture prediction using quantitative ultrasound (QUS) (Gluer, Wu et al. 
1993). Therefore, it has been proposed that composite measures of 
skeletal strength may be of greater value in general fracture prediction 
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than single site measurements, especially when these are from peripheral 
sites (Gatti, Sartori et al. 2001). 
Metacarpal morphometry by radiogrammetry is a non-invasive measure of 
skeletal strength from hand radiographs first described in 1960 (Barnett 
and Nordin 1960). There was little development in this modality of skeletal 
measurement until Horsman and Simpson described the 'six metacarpal 
hand index' in 1975 (Horsman and Simpson 1975). Traditional 
radiogrammetry never gained mainstream recognition as it was tedious 
and time consuming with measurements of metacarpal cortical thickness 
and bone width undertaken using fine needle callipers on hand 
radiographs. In the last 15 years, semi-automated techniques for 
metacarpal morphometry have been developed (Matsumoto, Kushida et 
al. 1994; Dey, McCloskey et al. 2000). More recently digital x-ray 
radiogrammetry (DXR) has been described where these measurements 
have been fully automated to significantly reduce both time and effort 
(Jorgensen, Andersen et al. 2000). DXR estimates skeletal strength from 
automated measurements of bone dimensions on hand radiographs and is 
expressed as composite indices such as DXR-BMD and metacarpal 
cortical index (DXR-MCI). So far, however, there have been only two 
studies published of the fracture predictive ability of DXR (Bouxsein, 
Palermo et al. 2002; Bach-Mortensen, Hyldstrup et al. 2006). This study 
was aimed at determining the ability of DXR indices to predict future 
vertebral fracture occurrence in osteoporotic women, and comparing their 
performance with that of DXA measurements at the spine and the hip. 
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5.3 METHODS 
5.3.1 SUBJECTS 
Vertebral Osteoporosis Trial (VOT): The VOT was a multicentre trial of 
clodronate (Bonefos®, Schering/Leiras Oy, Finland) for vertebral fracture 
prevention in women with osteoporosis (spine or hip T Score ~ -2.5 by 
DXA) and/or one or more vertebral fractures confirmed by plain 
radiograph. 
5.3.2 DESIGN 
VOT was designed as a randomised, placebo-controlled trial. Patients 
were recruited and followed up at 5 centres in the United Kingdom. They 
received daily oral clodronate 800mg or placebo for 3 years. All received a 
daily calcium supplement equivalent to 500mg of elemental calcium during 
the 3 years. 
5.3.3 DXR INDICES 
Subjects had plain hand radiographs taken at study entry. DXR indices 
were computed for each patient from the non-dominant hand on the plain 
radiographs using a commercially available DXR system (Sectra/Pronosco 
X-posure System™, Version 2.0, Sectra, Denmark). These comprised 
DXR-MCI and DXR-BMD as described below: 
5.3.3.1 DXR-MCI: 
The cortical index (CI) of a tubular bone is calculated as: CI = 2t / W, 
where t = cortical thickness and W = bone width of said bone. In DXR the 
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computation of MCI is fully automated and is calculated as a weighted 
average of the Cl's of the middle 3 metacarpals: MCI = (CI2+CI3+O.5CI4) / 
2.5 (Bouxsein, Palermo et al. 2002; Thodberg and Rosholm 2003). 
5.3.3.2DXR-BMD: 
This is computed using the formula for tubular bones as: OXR-BMO = e 7r t 
(1 - t /W), where 'e' is a constant representing the average mineral mass / 
unit volume of bone (Rosholm, Hyldstrup et al. 2001). 
5.3.4 OTHER MEASUREMENTS 
Patients had height and weight measured at baseline. Lumbar spine (L2-
L4 vertebrae) and total hip BMO were recorded in each patient at baseline 
and yearly follow-ups by OXA scanners at the study centres (Hologic aOR 
4500A, Hologic Inc., Bedford, USA). All the values were standardised 
subsequently across the study centres using the European spine 
phantom. 
5.3.5 FRACTURES 
Patients were followed up at 6-monthly intervals. Standard lateral 
radiographs of the thoracic and lumbar spines were obtained at baseline 
and annually thereafter. Baseline radiographs were put through vertebral 
morphometry using the semi-automated McCloskey method (McCloskey, 
Spector et al. 1993) and prevalent vertebral fractures were identified 
based on the computed vertebral height ratios. Only vertebrae that were 
normal at baseline were included in the evaluation for incident fractures on 
follow-up radiographs. Incident fractures had to fulfil the criteria for a 
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prevalent fracture and show a minimum decrease in height from the 
baseline film of 15% equalling 4.6mm or more (McCloskey, Selby et al. 
2001). 
5.3.6 STATISTICAL ANALYSIS 
Primary data were previously captured on Microsoft Access® based 
databases. For the purposes of this project, this data were transferred to, 
and were processed and analysed in the SPSS Version 11 statistical 
package. Baseline data of those who had a new vertebral fracture during 
the study period were compared to those who did not, using analysis of 
variance (ANOVA) and Chi-square tests. ROC curves were produced to 
study the relationship between measured skeletal indices and vertebral 
fracture incidence. Gradients of risk for 1 standard deviation (SD) 
decrease of each skeletal strength measurement and independent 
contribution to fracture risk was determined using univariate and 
multivariate regression models. Correlations between spine and hip BMD 
and DXR indices were calculated using Pearson coefficients. 
5.4 RESULTS 
Of the total of 593 women enrolled in the VaT, 538 (91%) had baseline 
hand radiographs available for evaluation by DXR, and were included in 
the present analysis. Ninety patients (16.7%) had one or more incident 
vertebral fractures during the study period. In the cohort, 243 patients had 
a prevalent vertebral fracture at baseline, of whom 76 went on to develop 
a new fracture; of the 295 who did not have a prior history, 14 developed 
vertebral fractures during the study period (relative risk = 6.6). 
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5.4.1 BASELINE CHARACTERISTICS 
The baseline characteristics of those with new vertebral fractures ('new-
fracture group') are compared to rest of the cohort without a new vertebral 
fracture (,non-fracture group') in Table 5.1. The new-fracture group were 
significantly older, and had significantly lower mean values for lumbar 
spine BMD, total hip BMD, DXR-BMD, and DXR-MCI. A significantly 
higher proportion of the new-fracture group had a history of prior vertebral 
fracture (84.4% vs. 37.3%, P<0.001). Although the new-fracture group 
were slightly shorter and lighter, there was no significant difference in 
mean body mass index (BMI) compared to the non-fracture group. 
Table 5.1. Baseline characteristics. 
New vertebral Rest of cohort P 
fraeture( s) (n=448) (ANOVA) 
(n=90) 
Age (years) 70.5±7.1 66.6±8 <0.001 
Height (em) 154.6±6.7 156.5±6.4 0.015 
Weight (kg) 58.9±11.7 61.1±11.2 0.091 
Body mass index (kg/m2) 24.6±4.3 24.9±4.2 0.49 
L2-L4 sBMD (mg/em2) 625±125 684±112 <0.001 
Total hip sBMD (mg/em') 608±102 651±11S 0.001 
DXR-BMD (gcm·2 ) 0.42±0.05 0.44±0.OS <0.001 
DXR-MCI 0.31±0.OS 0.34±0.06 <0.001 
Prior vertebral fracture (%) 76 (84.4) 167 (37.3) <0.001 a 
aChl-square test. 
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5.4.2 PERFORMANCE ACCORDING TO QUARTILES OF 
MEASUREMENTS AND ROC CURVES 
Measurements from the four skeletal measures were converted into 
quartiles and the distribution of the incident vertebral fractures was studied 
amongst the quartiles (Figure 5.1). For all four measures the highest 
incidence was in the lowest strength quartiles and lowest incidence in the 
highest strength quartiles (P<0.05 for all measures by Chi-square test). 
Figure 5.1. Incident vertebral fractures according to quartiles of 
measurements for each skeletal measure (Quartile 1 = lowest). 
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Receiver Operating Characteristic (ROC) curves were plotted using SPSS 
software to assess and compare the sensitivity and specificity of the 
skeletal measures in predicting incident vertebral fractures (Figure 5.2). 
The area-under-the curve (AUC) was highest for lumbar spine BMD (0.66), 
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but th is was more or less similar to that of OXR-MCI (0.65) . The AUC's for 
hip BMO and OXR-BMO were slightly lower (0.64 for both). 
Figure 5.2. Receiver Operating Characteristic (ROC) curves for 
incident vertebral fracture based on the four skeletal measures. 
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5.4.3 GRADIENTS OF RISK OF INCIDENT FRACTURE FOR 1 SO 
DECREASE IN MEASUREMENTS 
The absolute values of the skeletal strength measures were converted to 
standard deviation (SO) units. These values were entered into univariate 
regression models to derive the gradients of risk for incident vertebral 
fracture for 1 SO decrease in the measurements expressed as odds ratios 
(OR, 95%CI , Table 5.2) . The point estimates of the gradients of risk per 
1 SO decrease were similar for lumbar spine BMO and OXR-MCI (1 .82 and 
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1.81 respectively), and these were slightly higher than that for total hip 
BMD and DXR-BMD (1 .46 and 1.56 respectively). 
Table 5.2. Gradients of risk for incident vertebral fracture for 1 SO 
decrease in measurement (Univariate analysis, odds ratio, 95% 
confidence intervals). 
Odds Ratio , 95% CI P 
L2-L4 sBMD 1.82, 1.37-2.43 <0.001 
Total hip sBMD 1.46,1.16-1.85 0.001 
DXR-BMD 1.56,1 .23-1 .96 <0.001 
DXR-MCI 1.81 , 1.37-2.39 <0.001 
Figure 5.2A. OR's (point estimates) and 95% CI (high and low lines) 
from Table 5.2 plotted as a graph. 
2 .5T---------------------------------------~ 
.. 
.p" 
2 •• . . 
-
I • r-
• 0 ~ I 0 ~ 1.5·· 
-
I~ 
II) •• • 10 D:: 
0 •• 
... 
1 . . • . . . 
L2-L4 sBMD Total hip sBMD DXR-BMD DXR-MCI 
0.5 
Metacarpal Radiographic Indices In Bone Assessment 85 
5.4.4 INDEPENDENT PREDICTORS OF FUTURE FRACTURE 
RISK 
All the variables found to be significant in univariate analyses, including all 
the four skeletal strength measures, were entered into mUltivariate 
regression models (Table 5.3). In a forward conditional logistic regression 
model, lumbar spine BMO, OXR-MCI, and a history of prior vertebral 
fracture at baseline were found to be independent predictors of future 
vertebral fracture (P<O.05 for a" three). Of the three, prior history of 
vertebral fracture had the strongest association with future vertebral 
fracture risk with an OR of 6.84. 
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Table 5.3. Multivariate analysis (forward-conditional regression): 
Independent predictors of future vertebral fracture (odds ratio, 95% 
confidence interval). 
Odds Ratio, 95% CI P 
Age (yrs) 1.01,0.96-1.05 0.84 
Height (cm) 1.01,0.96-1.06 0.78 
L2-L4 sBMO (1S0 decrease) 1.56, 1.17-2.07* 0.003 
Total hip sBMO (1 SO decrease) 1.03,0.74-1.45 0.85 
OXR-BMO (150 decrease) 0.80, 0.43-1.50 0.48 
OXR-MCI 1.47,1.04-2.07* 0.027 
Prior vertebral fracture 6.84,3.66-12.78* <0.001 
*Independent predictors 
5.4.5 ASSOCIATION BETWEEN SKELETAL MEASURES 
The strength of association between any two skeletal measures was 
studied using Pearson correlation coefficients (Table 5.4). As expected 
correlation was highest between the two OXA measures (0.61), and 
between the two DXR measures (0.89). Although they had similar 
predictive ability for future vertebral fracture in univariate analysis, the 
correlation was the least between lumbar spine BMO and OXR-MCI (0.34). 
However, all correlations were statistically significant (P<0.001). 
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Table 5.4. Correlations amongst the various skeletal measures 
(Pearson coefficients, all P<O.001). 
T.hip sBMD DXR-BMD DXR-MCI 
L 1-L4 sBMD 0.61 0.37 0.34 
T. hip sBMD - 0.53 0.51 
DXR-BMD - - 0.89 
5.5 DISCUSSION 
In this study, low values of two DXR indices, DXR-BMD and DXR-MCI, 
were found to be associated with a significantly increased future risk of 
vertebral fracture. Their predictive abilities were similar to that of hip BMD 
and lumbar spine BMD respectively. DXR-MCI was able to predict 
vertebral fractures independently of other skeletal strength measures, 
including lumbar spine BMD. 
5.5.1 COMPARISONS AT BASELINE 
Women in the new-fracture group were significantly older than those in the 
non-fracture group in this analysis. This is consistent with what is already 
known regarding the relationship of vertebral fracture with age: for 
example, in a Finnish cohort, Santavirta and colleagues reported that in 
both sexes, the prevalence of thoracic vertebral fractures increased with 
age - after 40 years of age in men and after 55 years of age in women 
(Santavirta, Konttinen et at. 1992); and data from the European 
Prospective Osteoporosis Study (EPOS) also confirmed the rise in 
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incidence with age (EPOS 2002). However, the question of whether or not 
age is a risk factor for prevalent or incident vertebral fracture independent 
of BMD was not addressed in these two studies. In the current analysis, in 
multivariate regression models, age was not found to be a significant 
independent predictor of fracture risk suggesting that any association is no 
more than a reflection of lower bone density noted with older age. 
Although the mean body weight was lower in the new-fracture group, this 
was not statistically significant. The mean height was also somewhat lower 
in the new-fracture group (154.6cm vs. 156.5cm, P=0.015), but this could 
probably be a reflection of the fact that a significantly greater proportion in 
this group had a vertebral fracture at baseline (84.4% vs. 37.3%, 
P<0.001), and probably had already lost some height by the time of the 
baseline measurement. In fact, the mean BMI of both groups was nearly 
identical (24.6 vs. 24.9). This is similar to the analysis from EPOS in which 
Roy and colleagues reported a trend in both men and women, where 
increasing body weight and body mass index were associated with a 
reduced risk of vertebral fracture, although, apart from body mass index in 
men, the confidence intervals embraced unity (not significant) (Roy, O'Neill 
et al. 2003). In the current analysis, those with prevalent vertebral fracture 
at baseline had a much higher risk of new vertebral fracture than those 
without a baseline vertebral fracture (relative risk = 6.6). This is in keeping 
with previously published studies where prevalence of vertebral fracture 
was found to be a risk factor for not only future vertebral fracture (Ross, 
Genant et al. 1993; Lunt, O'Neill et al. 2003) but also non-vertebral 
fracture (McCloskey, Vasireddy et al. 2008). 
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The non-fracture group had significantly greater mean values (P<0.001) 
than the new-fracture group in all 4 skeletal measurements with 
differences in the lumbar spine BMD (0.68 g/cm2 vs. 0.62 g/cm2 
respectively, 9.7% difference), and DXR-MCI (0.34 vs. 0.31 respectively, 
9.7% difference), being of greater magnitude than the differences in total 
hip BMD (0.65 g/cm2 vs. 0.61 g/cm2 respectively, 6.6% difference), or 
DXR-BMD (0.44 g/cm2 vs. 0.42 g/cm2 respectively, 4.8% difference). The 
magnitude of the difference between the two groups is similar in DXR-
BMD and hip BMD, with both the differences being lower than with spine 
BMD; this is probably because both are 'remote' measurements with 
respect to the vertebral site. However, the difference between the two 
groups in mean DXR-MCI values (which is also a 'remote' index for the 
vertebral site) was as high as that with the spine BMD, suggesting that 
DXR-MCI may capture a component of skeletal strength not accounted for 
by the other measures. In the nested case-control analysis reported by 
Bouxsein and colleagues, mean lumbar spine BMD, DXR-BMD and DXR-
MCI were similarly higher in the control group (0.869 g/cm2, 0.495 g/cm2 
and 0.374 respectively) compared to the vertebral fracture group (0.753 
g/cm2, 0.459 g/cm2 and 0.340 respectively). Although these values are not 
directly comparable to the current analysis, as the cohort characteristics 
and the measuring devices including the Pronosco system (Version 1) 
were different, there was no comment made regarding the magnitude of 
the differences in the various measures between the vertebral fracture and 
control groups (Bouxsein, Palermo et al. 2002). 
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5.5.2 FRACTURE RISK BY UNIVARIATE ANALYSIS 
The finding that spine BMO is somewhat more specific than hip BMO for 
predicting risk of fracture at the vertebral site (site specificity) is as 
expected based on the previously published meta-analysis by Marshall 
and colleagues where a 1 SO reduction in spine bone density 
measurement was associated with a relative risk of 2.3 (1.9-2.8) for 
vertebral fracture (Marshall, Johnell et al. 1996). Bouxsein et ai, however, 
reported a slightly higher predictive ability of femoral neck BMO over 
lumbar spine BMO for vertebral fracture in their analysis (age-adjusted 
OR's 2.5 and 2.3 respectively) (Bouxsein, Palermo et al. 2002). In the 
current analysis, lumbar spine BMO and OXR-MCI fared equally well, the 
OR's being 1.8 for both measures. OXR-BMO achieved a gradient of risk 
somewhat lower than that for spine BMO or OXR-MCI. In fact, the gradient 
of risk was similar to the other remote index, total hip BMO (OR's 1.6 and 
1.5 respectively). In contrast, Bouxsein et al reported lower predictive 
ability of OXR-BMO and OXR-MCI (OR's 1.9 and 1.8 respectively) 
compared to OXA measures (above), although these are not directly 
comparable as the cohorts and measures were different to the current 
analysis, and OR's for all four measures were already age-adjusted in 
their report (Bouxsein, Palermo et al. 2002). Bach-Mortensen et al also 
reported an OR of 2.0 for 1 SO reduction in OXR-BMO for vertebral 
fracture, although no other skeletal measures were compared in their 
analysis of post-menopausal women from the Copenhagen City Heart 
Study (Bach-Mortensen, Hyldstrup et al. 2006). There is some evidence 
that bone geometry, particularly for compact skeletal segments, is a 
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determinant of its strength at least as important as bone density (Gluer, 
Wu et al. 1993; Gatti, Sartori et al. 2001). While DXR indices might capture 
a component of bone strength determined by other areal properties of 
bone, the similar OR's for DXR-MCI and lumbar spine DXA are more likely 
to be a statistical quirk in view of the relatively modest number of incident 
fractures studied, as the point estimates are within the CI's of the other 
two measures. 
5.5.3 INDEPENDENT PREDICTORS ON MULTIVARIATE 
ANALYSIS 
In multivariate regression models, hip BMD and DXR-BMD were not 
independently related to fracture risk with OR's of 1.0, 0.7-1.4; and 0.8, 
0.4-1.5 respectively. In fact, in a forward-conditional logistic regression 
model only spine BMD, DXR-MCI and baseline history of prior vertebral 
fracture were significantly and independently associated with fracture risk 
(P<0.001). Bouxsein and colleagues did not report any analysis for 
independent predictors for fracture among the skeletal measures they 
studied. The finding of lumbar spine BMD as an independent predictor in 
the present study is as expected, as it is the local index of skeletal 
strength. History of prior vertebral fracture has also been shown to be a 
risk factor for future fracture in previous stUdies and is therefore an 
expected result in the current analysis. It is difficult to provide a biological 
explanation for the similar predictive abilities of DXR-MCI and lumbar 
spine BMD, apart from the suggestion above that DXR-MCI captures a 
component of skeletal strength determined by bone geometry or other 
attributes inaccessible to DXA, particularly as the correlation of DXR-MCI 
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with lumbar spine BMD was the least amongst the skeletal measures in 
this analysis (Pearson correlation coefficient 0.34). 
5.5.4 POTENTIAL LIMITATIONS 
The relatively small number of fractures studied meant that while the point 
estimates of the various OR's reached statistical significance, the 
confidence intervals were relatively wide. The setting of this study was a 
controlled trial of clodronate, and the selection of subjects was based on 
this, rather than a population-based cohort, which could probably have 
provided a more robust basis for evaluation of DXR. When this project was 
conceived, and analyses were completed and published as abstracts 
(Abstracts 4 and 6 listed at the beginning of the thesis), the randomisation 
information of the trial had remained undisclosed. Subsequent publication 
from the study confirmed the efficacy of clodronate in reducing the 
vertebral fracture incidence by 46% (McCloskey, Selby et al. 2004). This 
fracture-reducing effect of clodronate will need to be taken in to account in 
assessing the gradients of risk for fracture of the various measures, and it 
would be interesting to study if there is any effect on odds ratios when 
adjusted for clodronate treatment in multivariate regression analysis. One 
possibility is that, in an untreated population the gradients of risk could be 
greater than the findings presented here. For example, the OR for lumbar 
spine BMD for vertebral fracture risk in our study (OR 1.6, 1.2-2.1) was 
lower than the relative risk previously reported by Marshall and colleagues 
in a meta-analysis of untreated patients (RR 2.3, 2.0-3.5) (Marshall, 
Johnell et al. 1996), or indeed the OR reported by Bouxsein and 
colleagues (OR 2.3, 1.8-2.9) discussed earlier, where the subjects were 
Metacarpal Radiographic Indices In Bone Assessment 93 
from the Study of Osteoporotic Fractures which had no treatment 
intervention (Bouxsein, Palermo et al. 2002). 
It is also possible that the spinal and peripheral skeletal strength are 
altered differently with clodronate treatment affecting the gradients of risk 
for the various skeletal measures differently. However, in the timescales 
similar to this study (3 years), any treatment such as clodronate is likely to 
have only a relatively small impact on a comparison of techniques within 
the same population as in the current study. It is intended that these 
issues will be addressed when preparing the analyses for publication in 
the near future when randomisation data will be available and added to the 
database and processed appropriately. 
5.6 CONCLUSIONS 
In this study, DXR-BMD and DXR-MCI were found to be comparable to hip 
or lumbar spine BMD as indicators of future vertebral fracture risk in 
osteoporotic women. In addition, DXR-MCI may capture a component of 
skeletal strength, and risk for vertebral fractures that is not accounted for 
by the other measures of skeletal strength studied. These simple 
measures may have wide applicability (especially where DXA is not 
available) since hand radiographs and DXR are relatively inexpensive. 
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6.1 ABSTRACT 
Introduction: The assessment and management of osteoporosis and 
fractures is expensive for national health systems. To improve fracture 
prediction in a cost-effective manner, effective utilisation of existing 
techniques will need to be supplemented by introduction of more 
affordable and widely available newer techniques. Metacarpal cortical 
index (MCI) is known to predict future fracture risk. In this study a new, 
rapid semi-automated technique to derive MCI from hand radiographs 
using a digitising tablet was evaluated. 
Methods: Subjects were 4929 women aged 75 years or older participating 
in the MRC HIPS study which was designed to evaluate risk factors for 
fracture combined with a placebo-controlled trial of oral clodronate 
(Bonefos®) for fracture prevention. Bilateral hand radiographs were 
obtained at baseline and the measurements were captured using a 
transparent cross-hair cursor with the films placed on a backlit digitising 
tablet and stored automatically in an electronic database. The length, total 
bone width and cortical thicknesses of the second to fourth metacarpals of 
both hands were measured. The MCI was calculated for both hands 
separately and an average value was also derived (AMCI). 
Results: During a median follow-up of 4 years, 792 women sustained at 
least one fracture; of these 180 sustained hip fractures and 658 sustained 
non-hip fractures. At baseline, these women had Significantly lower total 
hip BMD, forearm BMD and AMCI (all PSO.001). In univariate analysis the 
gradient of risk of fracture (odds ratio, 95% CI) for 1 standard deviation 
decrease in AMCI was 1.42, 1.22-1.65 for hip fractures; and 1.30, 1.20-
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1.40 for all fractures. The corresponding ORs for total hip BMD were 2.09, 
1.80-2.43 and 1.61, 1.49-1.74 respectively, and for forearm BMD were 
1.79, 1.52-2.11 and 1.47, 1.35-1.59 respectively. The gradients of risk with 
AMCI were either similar or higher than with unilateral MCI. However, 
SMCM indices were not significantly predictive of incident clinical vertebral 
fractures. After adjusting for significant extra-skeletal variables, AMCI 
remained significantly associated with both hip fractures and all fractures. 
However, after adjusting for total hip BMD, AMCI was not significantly 
predictive of fracture risk. 
Conclusions: AMCI computed using this rapid technique is an indicator of 
future fracture risk in elderly women in the community. As hand 
radiographs are inexpensive and easy to access, this technique could 
have wide applicability in screening and management of osteoporosis in 
the community, especially where access to DXA is limited. 
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6.2 INTRODUCTION 
Osteoporotic fractures cause significant morbidity and their management 
is a significant expense in the health systems of developed countries and 
is likely to become so in developing countries (Genant, Cooper et al. 
1999). The prevention of osteoporotic fractures by anti resorptive treatment 
and other measures is also a considerable expense and this has made 
identification of those at highest risk of fracture a priority for cost-effective 
prevention (NICE 2008; Tosteson, Burge et al. 2008). Despite the need, 
however, availability of, or access to diagnostic services is poor in several 
parts of the world (Genant, Cooper et al. 1999). 
A number of risk factors including low bone mineral density (BMD) 
predispose to osteoporotic fractures. The currently accepted definition and 
diagnosis of osteoporosis is based on T score derived from measurements 
of BMD by dual-energy x-ray absorptiometry (DXA) (Kanis 1994). 
However, setting up and running a bone densitometry service using DXA 
requires considerable resources including space and this may be an 
important limiting factor in providing diagnostic services in resource 
deprived areas. DXA may also have some limitations as an only 
assessment tool for osteoporotic fractures (Nielsen 2000). There is some 
evidence to suggest that composite measures of skeletal strength may be 
of more value in fracture prediction than single measurements (Gluer, Wu 
et al. 1993; Gatti, Sartori et al. 2001). Therefore, to improve fracture 
prediction and prevention in a cost-effective manner, a combined 
approach is needed involving effective utilisation of existing techniques 
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and knowledge of risk factors, and also introducing affordable and 
potentially more widely available techniques. 
Metacarpal morphometry (MCM) from hand radiographs (radiogrammetry) 
was one of the earliest methods described for systematic skeletal strength 
assessment and diagnosis of osteoporosis (Barnett and Nordin 1960). 
Traditional radiogrammetry, involved tedious and time consuming 
measurements of metacarpal dimensions using callipers and subsequent 
manual calculations. It therefore never gained mainstream recognition, 
especially with the advent of newer automated technologies such as single 
energy x-ray absorptiometry (SXA) and later DXA with the capability of 
measuring BMD at central sites. More recently, with the renewed interest 
in less expensive and potentially more widely available technologies, 
semi-automated techniques for MCM have been described which improve 
on the time and effort involved in obtaining measurements by traditional 
MCM (Matsumoto, Kushida et al. 1994; Yamamoto, Yuu et al. 1994). A 
fully automated system of digital x-ray radiogrammetry (DXR) has also 
been described since (Jorgensen, Andersen et al. 2000) and has been 
commercially available. 
A rapid, semiautomated MCM (SMCM) technique was developed in-house 
at the WHO Collaborating Centre in Sheffield, involving a back-lit digitising 
tablet. This technique was compared to a commercially available MCM 
technique (Bonalyser®, Teijin Corporation, Japan) in a cohort of 178 
osteoporotic women (mean age 70 years), and both were found to have 
similar intra-observer reproducibility of metacarpal cortical index (MCI) of 
the second metacarpal, which is a principal measure of MCM (Dey, 
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McCloskey et al. 2000). Although in that study, it was shown to be 
significantly associated with prevalent vertebral fracture, SMCM has not 
been tested for prospective incident fracture predictive ability previously. In 
this study was aimed at an evaluation of this technique in a large 
prospective setting, including comparisons with DXA and DXR. 
6.3 METHODS 
6.3.1 SUBJECTS 
MRC Hip Fracture Prevention Study (HIPS): HIPS was the largest single 
centre osteoporosis study in elderly women based at Sheffield, UK. The 
study aimed to identify risk factors associated with hip fracture and 
determine the efficacy of clodronate (Bonefos®, Leiras Oy, Finland.), an 
oral bisphosphonate, in fracture prevention. 5212 community-dwelling 
caucasian women aged 75 years or over were recruited to the study. 
6.3.2 DESIGN 
The study was conducted as a randomised, double-blind placebo 
controlled trial of clodronate. All subjects received either oral clodronate 
800mg daily or identical placebo for 3 years and were followed for up to a 
further 2 years. Extensive baseline data were collected at recruitment and 
this included height, weight, fracture and medical history and all had 
baseline measurements and investigations including hand radiographs. 
This particular analysis included 4929 subjects (94.6% of HIPS cohort) 
who had analysable SMCM measurements from baseline hand 
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radiographs. From the same radiographs, a subgroup of 654 subjects also 
had DXR measurements of the non-dominant hand. 
6.3.3 SEMI-AUTOMATED METACARPAL MORPHOMETRY 
This new technique was developed at Sheffield to derive the MCI from 
hand radiographs. A backlit digitising tablet and a transparent cross-hair 
cursor with click-buttons were developed to measure distances between 
two points. For example, the distance between points A & B were 
measured by clicking on point A and moving the cursor over the digitising 
tablet to point B and clicking a second time. A software program was 
developed to automatically record the distance between the two clicks. 
The program algorithm allowed for a set sequence of clicks to record 
several measurements in sequence automatically without any further 
operator input. 
The length, diameter (bone width) and the cortical thicknesses of the 
second to fourth metacarpals of both hands were captured using the 
cross-hair cursor on films placed on the digitising tablet and stored 
automatically in an electronic database. The data were subsequently 
transferred to the SPSS statistical package and processed. 
6.3.3.1 Metacarpal Cortical Index 
The cortical index of a tubular bone has traditionally been calculated as 
follows: CI= medial+lateral cortical thickness/bone width. 
The MCI was calculated as a weighted average of the middle 3 
metacarpals as follows: MCI = (CI2+Cb+0.5CI4)/2.5. 
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MCI was coded and analysed by non-dominant and dominant sides 
(NDMCI & DMCI). Average MCI was then computed as follows: AMCI = 
(NDMCI+DMCI)/2. 
6.3.4 DXA MEASUREMENTS 
Baseline BMD by DXA was performed for the hip on a Hologic QDR4500A 
scanner (Hologic Inc., Bedford, USA), and for the forearm using an 
Osteometer DTX200 (Osteometer Inc., Hawthorne, USA). 
6.3.5 DXR MEASUREMENTS 
In the smaller subgroup of 654 patients, the following DXR measurements 
were obtained using the Pronosco X-posure System Version 2.0 (Sectra 
Pronosco, Denmark). 
6.3.5.1 DXR-MCI: 
The cortical index (CI) of a tubular bone is calculated as: CI = 2t I W, 
where t = cortical thickness and W = bone width of said bone. DXR-MCI is 
computed in an automated sequence as a weighted average of the crs of 
the middle 3 metacarpals: MCI = (C/2+C/3+0.5C/4)) / 2.5 (Bouxsein, 
Palermo et al. 2002; Thodberg and Rosholm 2003) .. 
6.3.5.2DXR-BMD: 
This is computed using the formula for tubular bones as: DXR-BMD = e 7r t 
(1 - t IW), where 'e' is a constant representing the average mineral mass / 
unit volume of bone (Rosholm, Hyldstrup et al. 2001). 
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6.3.6 FRACTURES 
All subjects were followed up every 6 months by study nurses. Data 
collected included incident fracture history. All incident fractures which 
were clinically reported were confirmed independently and classified by 
reviewing the relevant x-ray or x-ray report. 
6.3. 7 STATISTICS 
The primary HIPS data and the initial data captured from SMCM were 
collected on databases derived from Microsoft Access. Data were 
transferred and final processing and statistical analysis was performed 
using the SPSS Version 11.x statistical package. Baseline characteristics 
of the whole cohort and fracture subgroups were studied using ANOVA. 
MCI measurements between left/right and nondominantldominant side 
subgroups were compared using paired t-tests. Gradients of risk for 
incident fracture for 1 standard deviation decrease in measurement of 
skeletal strength were studied using univariate and multivariate 
regression. Correlations between the various skeletal measures were 
studied using Pearson correlation coefficients. A P value of <0.05 was 
considered statistically significant. 
6.4 RESULTS 
The median follow up period for the study was 4 years. In the analysed 
cohort, 792 (16.1%) women sustained at least one fracture during the 
study. Of these, 180 (3.7%) sustained at least one hip fracture, and 658 
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(13.3%) sustained at least one non-hip fracture. The non-dominant side for 
the majority (96%) was the left side as expected. 
6.4.1 BASELINE CHARACTERISTICS 
At baseline, the fracture groups had significantly lower weight, hip and 
forearm BMD, and MCI indices (all P<0.05) (Table 6.1). The hip and axial 
(non-vertebral) fracture subgroups were also Significantly older (mean 81.0 
and 80.2 yrs respectively vs. 79.5 yrs for study cohort, P<0.001), while 
there was no significant difference in the appendicular fracture group. At 
baseline there was no difference in AMCI between the clodronate and the 
placebo groups (0.49±0.07 for both). Clodronate treatment had no 
Significant effect on incident hip or other fracture types other than on 
incident appendicular fracture, where there was a statistically significant 
decrease. 
MCI SUbtypes: The mean NDMel was significantly higher compared to the 
DMCI in the study cohort as a whole (0.51 and 0.47 respectively, paired t-
test P<0.001). Mean bone width was higher on the dominant side (8.14 vs 
8.04, P<0.001), but this was off-set by lower mean cortical thickness (1.93 
vs. 2.07, P<0.001), producing a lower mean DMCI compared to NDMC!. 
Similarly, mean NDCI2 was higher compared to DCb (0.52 and 0.49 
respectively, P<0.001). These trends were noted in the individual fracture 
groups as well with the non-dominant side values being higher than the 
dominant side. 
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Table 6.1. Baseline characteristics (mean ± SO). 
Study Hip fractures Appendicular Vertebral Axial (non-vert) All fractures 
cohort 
Number (%) 4929a 1BO(3.7) 449 (9.1) 77 (1.6) 1B9 (3.B) 792 (16.1) 
Age (years) 79.5±3.9 B1.0±4.6* 79.3±3.B 79.9±3.B BO.2±4.0** 79.9±4.1** 
Height (cm) 155.9±6.1 154. 9±6.1 ** 156.2±6.1 154.9±506 155.5±6.4 155.8±6.1 
Weight (kg) 65.1±12.0 59.3±10.3* 64.1±10.B 62±9.5** 62.2±12.7* 63.0±11.2* 
Body mass index 26.B±4.6 24.7±4.0* 26.3±4.1** 25.8±3.9 25.7±4.7** 25.9±4.3 
T. hip BMD (gcm-z) 0.75±0.14 0.65±0.13* 0.71±0.14* 0.70±0.13* 0.70±0.15* 0.70±O.14* 
Fern neck BMD (gcm-Z) 0.65±0.12 0.56±O.09* 0.61±O.11* O.61±0.12** 0.60±0.11* 0.60±0.11* 
Forearm BMD (gcm-z) 0.34±0.08 0.30±0.07* 0.32±0.07* 0.32±0.07** 0.31±0.O8* O.32±0.07* 
AMCI O.49±0.07 0.47±0.07* 0.4B±0.06* 0.49±0.OB 0.47±0.07* 0.4B±0.07* 
NDMCI 0.51±0.08 0.49±0.08* 0.49±0.07* 0.51±0.09 0.49±0.07* 0.49±0.07* 
I 
DMCI 0.47±0.OB 0.45±0.07* 0.46±0.07** 0.47±0.OB O.45±0.07* 0.46±0.07* 
NDClz 0.52±0.09 0.49±0.09* 0.50±0.09* 0.51±0.1 O.50±0.08* 0.50±O.09* 
DCb 0.49±0.09 0.47±0.OB* O.4B±O.OB** 0.50±0.O9 0.47±0.08* O.48±0.08* 
Clod ron ate treated (%) 2466 (50) 84 (47) 200 (45)* 34 (44) 97 (51) 367 (46)** 
-
L- ___ _ __ 
a94.6% of HIPS cohort; ANOVA and Chi-square test (clodronate treatment): *P::;O.001; **P<O_OS. 
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6.4.2 PERFORMANCE ACCORDING TO QUARTILES OF 
MEASUREMENTS AND ROC CURVES 
Total hip BMD, forearm BMD and AMCI measurements were divided into 
quartiles of skeletal strength (1 =Iowest) and cumulative incidence of all 
fractures in each quartile for the three measures are shown in Figure 6.1. 
This shows the steepest distribution in hip BMD quartiles, suggesting it to 
be the most discriminating measure. Incidence in quartiles of forearm BMD 
was similar to AMCI. 
Figure 6.1. Cumulative incidence (Ufo) of all fractures in quartiles of 
hip BMD, forearm BMD and AMCI (1=lowest). 
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Receiver operating characteristics (ROC) curves were produced for total 
hip BMD, forearm BMD and AMCI to study their performance in the overall 
identification of incident fractures (Figures 6.2 and 6.3). The areas-under-
the-curve (AUC's) suggest that all 3 measures performed moderately well 
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in all-fracture identification (Table 6.2) . Hip BMD was however somewhat 
superior when individual fracture types were studied, while the AUC of 
AMCI for vertebral fracture identification was insignificant. 
Figure 6.2. Receiver operating characteristics (ROC) curves for 
skeletal measures at baseline: performance in identification of 
incident hip fracture. 
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Figure 6.3. Receiver operating characteristics (ROC) curve for 
skeletal measures at baseline: performance in identification of any 
fracture (cumulative all-fracture incidence). 
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Table 6.2. Performance of skeletal measures in incident fracture 
identification: areas-under-the-curve (standard error) based on ROC 
curves. 
Hip Appendicular Vertebral Axial (non- All fractures 
fractures vertebral) 
Total hip 0.71 (0.02) 0.60 (0.01) 0.61 (0.03) 0.62 (0.02) 0.63 (0.01) 
BMD 
Forearm 0.65 (0.02) 0.58 (0.01) 0.59 (0.03) 0.61 (0.02) 0.60 (0.01) 
BMD 
AMCI 0.61 (0.02) 0.57 (0.01) 0.51 (0.04) 0.58 (0.02) 0.58 (0.01) 
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6.4.3 GRADIENTS OF FRACTURE RISK FOR 1 STANDARD 
DEVIATION DECREASE IN MEASUREMENT 
All measurements were converted into standard deviation units compared 
to the mean. These were put through regression analyses to obtain 
gradients of risk for each SO decrease in measurement expressed as 
odds ratios (OR's) and 95% confidence intervals (Table 6.3) . In univariate 
regression analysis hip BMD and its subtypes were the strongest 
predictors of both hip and non-hip fracture with the highest OR's followed 
by forearm BMO. The OR's for SMCM indices were lesser for hip, 
appendicular and axial (non-vertebral) fractures with AMCI , NOMCI, and 
NDCI2 faring better than DMCI and DCI2. None of the SMCM indices were 
significantly predictive of incident clinical vertebral fractures. 
After adjustment for significant extra-skeletal variables, hip, appendicular 
and axial (non-vertebral) fracture prediction remained significant with all 
the measures (Table 6.4). In all cases, trends noted in univariate analyses 
were preserved with hip BMD remaining the strongest predictor of hip and 
other fractures. 
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Table 6.3. Gradients of fracture risk for 1 SO decrease in baseline measurement expressed as odds ratios, 95% confidence 
intervals. 
Hip fractures Appendicular Vertebral Axial (non-vert) All fractures 
Total hip BMO 2.09,1.80-2.43 1.42, 1.29-1 .52 1 .47, 1. 18-1 .84 1.54, 1.34-1.78 1 .61 , 1 .49-1 .74 
Femoral neck BMO 2.47, 2.07-2.97 1.42, 1.28-1 .58 1.45, 1.13-1 .85 1.53, 1.31 -1.80 1.64, 1.51-1 .79 
Forearm BMO 1.79, 1.52-2.11 1.33, 1.20-1.47 1.43, 1.13-1 .82 1.52, 1.30-1 .78 1.47, 1.35-1 .59 
AMCI 1.42, 1.22-1.65 1.24, 1.12-1 .37 1.06, 0.84-1 .32 1.33, 1.14-1 .53 1.30, 1.20-1.40 
NOMCI 1.38, 1.19-1 .61 1.27, 1.15-1.40 1.08, 0.86-1 .35 1.28, 1.11-1.48 1.30, 1.20-1.40 
OMCI 1.38, 1.19-1 .60 1.17, 1.06-1 .29 1.03, 0.82-1.28 1.32, 1.14-1 .52 1.24, 1.15-1 .34 
NOCI2 1.41 , 1.22-1 .64 1.21 , 1.09-1 .33 1.15, 0.92-1.44 1.28, 1.11-1.49 1.26, 1.17-1 .36 
OCI2 1.41 , 1.21-1 .64 1.15, 1.04-1 .26 0.98, 0.78-1 .23 1.32, 1.14-1 .53 1.22, 1.13-1 .31 
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Table 6.4. Gradients of fracture risk for 1 SO decrease in measurements adjusted for extra-skeletal variables significant in 
univariate analysis: age, height and weight for hip fracture; BMI and clodronate treatment for appendicular fractures; and 
age and weight for axial (non-vertebral) fractures (forward-conditional regression). Odds Ratios, 95% confidence intervals. 
Hip fractures Appendicular Axial (non-vert) All fractures 
Total hip BMO 1.81 , 1.53-2.16 1.42,1.28-1 .56 1.54, 1.34-1.78 1.61 , 1.49-1 .74 
Forearm BMO 1.40, 1.15-1 .70 1.33, 1.20-1.47 1.52, 1.30-1 .78 1.46, 1.35-1 .59 
AMCI 1.21 , 1.03-1.42 1.24, 1.12-1.37 1.27, 1.09-1 .48 1.26, 1.16-1 .36 
NOMCI 1.19, 1.01-1 .40 1.27,1. 15-1 .40 1.23, 1.06-1.43 1.26, 1.17-1 .36 
NOCI2 1.22, 1.04-1.44 1.20, 1.09-1 .33 1.23, 1.06-1.43 1.22, 1.13-1 .33 
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6.4.4 INDEPENDENT PREDICTORS OF FUTURE FRACTURE 
All variables significant at baseline were entered into multivariate logistic 
regression models to derive independent associations with fracture risk. 
Total hip BMD was an independent predictor for all fractures (Table 6.5). 
In addition, age and weight were independent predictors of hip fracture. 
Forearm BMD was an independent predictor of axial (non-vertebral) 
fracture but not of other types. Clodronate treatment was independently 
associated with reduced appendicular fracture risk. Although independent 
of age, weight and clodronate treatment as mentioned previously, AMCI 
was no longer significantly associated with either hip or other fracture type 
after adjustment for hip BMD. 
Jf&/dCJ!jJJIIr'Jt!lO;!8jJ/JIC l!Jt!lces III /fCJlle Assessment lit, 
Table 6.5. Independent predictors of future fracture: mUltivariate regression analysis. 
Hip fractures Appendicular Axial (non-vert) All fractures 
Age (yrs) 1.04,1.01-1.08* - 1.02, 0.98-1.05 1.00, 0.98-1.02 
Height (cm) 1.02, 0.99-1.05 - - -
Weight (kg) 0.98,0.97-1.00* - 1.00, 0.98-1.02 1.00,1.00-1.01 
Total hip BMO (1 SO decrease) 1.81,1.53-2.16* 1.42, 1.29-1.57* 1.36, 1.12-1.64* 1.50, 1.35-1.66* 
Forearm BMO (1S0 decrease) 1.00, 0.78-1.27 1.06,0.92-1.23 1.24, 1.01-1.51* 1.12,1.01-1.25* 
AMCI (1S0 decrease) 1.01, 0.83-1.23 1.07, 0.95-1.21 1.05, 0.88-1.27 1.05, 0.95-1.16 
Clod ron ate rx - 0.79,0.65-0.96* 1.07, 0.86-1.43 0.83,0.71-0.98* I 
*Forward-conditional regression, P<O.05. 
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6.4.5 ASSOCIATIONS BETWEEN DXA AND SMCM INDICES 
The correlation between hip and forearm BMO and SMCM indices was 
studied using scatter plots (Figures 6.4, 6.5 and 6.6) , and Pearson 
coefficients (Table 6.6). AMCI had somewhat better correlations with both 
OXA indices than NOMCI although all correlations were significant. AMCI 
had stronger correlation with forearm than hip BMD. 
Figure 6.4. Scatter plot showing correlation between AMCI and total 
hip BMD by T scores . 
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Figure 6.5. Scatter plot demonstrating correlation between AMCI and 
DXR-MCI. 
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Figure 6.6. Scatter plot demonstrating correlation between AMCI and 
forearm BMD. 
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Table 6.6. Correlations between DXA and SMCM indices (Pearson 
coefficients, all P<O.001). 
Forearm BMO AMCI NOMCI 
Total hip BMO 0.65 0.41 0.38 
Forearm BMO - 0.56 0.51 
AMCI - - 0.93 
6.4.6 COMPARISONS AND ASSOCIATIONS BETWEEN DXR 
AND SMCM INDICES 
In the study group, 654 subjects also had OXR indices measured from the 
non-dominant hand. Of the MCM indices, OXR-BMO correlated best with 
AMCI (0.73) in this subgroup (Table 6.7). There were significant 
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differences (t-tests P<0.001) between mean OXR-MCI (O.32±0.05) and 
mean values of AMCI, NOMCI and OMCI (0.49±0.07, 0.51±0.08 and 
0.47±0.08 respectively). Although mean OXR-MCI was closest to mean 
DMCI, correlation was best with AMCI (0.85) and less with NDMCI and 
DMCI (0.81 and 0.79 respectively). 
Table 6.7. Correlations between DXR and SMCM indices (Pearson 
coefficients, all P<O.001) . 
DXR-MCI AMCI NOMCI OMCI 
DXR-BMD 0.90 0.73 0.68 0.67 
DXR-MCI - 0.86 0.81 0.79 
6.4.7 DIAGNOSIS OF OSTEOPENIA AND OSTEOPOROSIS BY 
AMCI 
Using the WHO definitions of osteopenia and osteoporosis based on total 
hip BMD (T scores <-1 and <-2.5 respectively) ROC curves were produced 
to illustrate the diagnostic ability of AMCI (Figures 6.7 & 6.8). The areas 
under the curve (AUC's) for diagnosis of both osteopenia and 
osteoporosis were similar (0.70, SE 0.01). Based on the ROC curves, 
three thresholds were chosen to derive sensitivity, specificity, positive 
predictive value and negative predictive value for both diagnoses and 
findings are summarised in Table 6.8. These suggest that an AMCI > 
0.535 rules out osteoporosis with a high negative predictive value (92.1 %) 
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and an AMCI < 0.485 suggests a diagnosis of osteopenia/osteoporosis 
with a high positive predictive value (81.2%). 
Figure 6.7. ROC curve illustrating performance of AMCI in diagnosing 
osteoporosis (T. hip T score < -2.5). 
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Figure 6.8. ROC curve illustrating performance of AMCI in diagnosing 
osteopenia or osteoporosis (T. hip T score <.1). 
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Table 6.8. Performance of various AMCI thresholds in diagnosing osteopenia/osteoporosis (T. hip T score <-1) 
and osteoporosis (T. hip T score <-2.5). PPV=positive predictive value & NPV=negative predictive value. All 
values as percentages. 
AMCI Osteopenia Osteoporosis 
threshold Sensitivity Specificity PPV NPV Sensitivity Specificity PPV NPV 
<0.485 54.3 73.1 81.2 41.3 69.5 59.5 27.5 89 
<0.507 67.8 60.6 78.9 45.2 80.3 54.2 24.7 90.4 
<0.535 82.0 44.8 76.4 52.1 90.0 29.9 22.2 92.1 
--
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6.5 DISCUSSION 
In this study the ability of a new SMCM technique in predicting fracture risk 
was analysed and compared with other measures of skeletal strength. Hip 
and forearm BMO were significantly lower in all fracture groups. SMCM 
indices were significantly lower in hip, appendicular and axial (non-
vertebral) fracture groups at baseline but not in the clinical vertebral 
fracture group. AMCI had slightly higher predictive ability for various 
fracture types than NOMCI or OMCI, but this was lower than that of hip 
and forearm BMO. None of the SMCM indices were significantly predictive 
of clinical vertebral fracture risk. 
6.5.1 HAND DOMINANCE AND MCI 
Although MCM has been traditionally performed on the non-dominant side, 
there have been few papers commenting on the effect of handedness, 
with particular reference to fracture risk assessment. In our study, NOMCI 
was significantly higher than OMCI across the whole cohort. This is in 
contrast to a recent report of significantly higher MCI on the dominant side 
in right handed people (0.62 vs 0.61, P==0.02), but no significant difference 
in left handed people (Vehmas, Solovieva et al. 2005). However, this study 
included only 543 subjects, the MCI was calculated from the 2nd 
metacarpal alone, and the difference was small although statistically 
significant. 
In another study comparing the structure of the 2nd metacarpal based on 
hand dominance, Roy et al found that overall cortical thickness did not 
show significant side-related differences for either handedness although 
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significant periosteal and endosteal expansion of the second metacarpal 
cortex was noted on the dominant side, in both left- and right-handers 
(Roy, Ruff et al. 1994). Similarly, as noted earlier, in the present study 
mean bone width was higher on the dominant side, but this was off-set by 
lower mean cortical thickness, producing a lower mean DMCI compared to 
NDMC/. A greater loss of metacarpal cortical thickness in women 
compared to men after the 5th decade has been reported previously (Plato 
and Purifoy 1982). However, the mechanism for a differential loss 
producing a lower cortical thickness in either hand compared to the other 
is unclear. 
6.5.2 PREDICTING FUTURE FRACTURE RISK 
The performance of total hip and femoral neck BMD in predicting hip 
fracture (OR's 2.09 and 2.47 respectively) was somewhat lower than that 
reported by Bouxsein and colleagues for femoral neck BMD (relative 
hazard 3.0), but they used a case-cohort approach using a smaller, 
fracture-rich study group (Bouxsein, Palermo et al. 2002). Our results were 
closer to those reported in a meta-analysis of prospective studies where 
the relative risk for hip fracture was 2.6 for measurement at the hip 
(Marshall, Johnell et al. 1996). 
The SMCM indices performed similarly in predicting future fracture risk in 
our study with AMCI performing slightly better than the other indices. A 
fairly large intra-observer reproducibility error (CV=9.37%) was reported 
previously with the SMCM technique in acquiring unilateral MCI from a 
single (right second) metacarpal (Dey, McCloskey et al. 2000). AMCI is a 
composite measurement from six metacarpals rather than a single 
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metacarpal. This may have reduced the confounding effect of 
measurement error providing a more accurate skeletal strength 
assessment resulting in the somewhat better performance noted in 
fracture prediction compared to the single metacarpal measures (DCb and 
NDCb). 
SMCM indices did not predict clinical vertebral fracture risk although non-
vertebral axial fracture risk was predicted. In three previous studies 
metacarpal indices have been shown to predict vertebral fracture risk 
(Dey, McCloskey et al. 2000; Bouxsein, Palermo et al. 2002; Bach-
Mortensen, Hyldstrup et al. 2006). The first two of these studies used non-
prospective approaches on smaller cohorts using patients known to have 
(and therefore essentially prevalent) vertebral fractures and comparing 
them to controls. The prospective study reported by Bach-Mortensen et al 
had a longer mean follow-up of 6.1 years (compared to mean of 4 years 
for the present study), and while they reported an OR of 2.0 for vertebral 
fracture with 1 SO decrease in DXR-BMD, DXR-MCI was not reported on 
for any of the fracture types studied. In the present study only clinically 
reported and confirmed vertebral fractures were included prospectively, 
and regular radiological screening of the whole cohort was not undertaken 
to confirm all incident vertebral deformities. However, it is known that the 
majority of vertebral fractures are silent (Ziegler, SCheidt-Nave et al. 1996; 
McKiernan 2009). The incidence of vertebral fracture has been reported 
as 10.7/1000 per year in European women over 50 years (EPOS 2002). In 
fact, in the HIPS cohort itself, at baseline the prevalence of vertebral 
fracture was 14.5% by vertebral fracture analysis of densitometer acquired 
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images (McCloskey, Vasireddy et al. 2008). The cumulative incidence of 
radiological vertebral fractures is therefore likely to have been higher than 
the clinically reported fractures (1.6%, Table 6.1) in the present study. It 
may be speculated that SMCM indices may have been predictive if all 
radiologically detectable vertebral deformities were included in the 
analysis, particularly, as noted in Table 6.3, there was a trend for NDCI2 
for predicting vertebral fractures with an OR of 1.15 for 1 SO decrease, 
although the confidence intervals embraced unity. Another possibility may 
be that perhaps, SMCM measures are more geometric, structural indices 
rather than density indices, and the latter may be of more value in 
predicting vertebral fractures. However, this explanation seems less likely, 
as DXR-MCI in the VaT cohort (Chapter 5), also calculated similarly, not 
only significantly predicted incident morphometric vertebral fractures 
(cumulative incidence 16.7% over a similar follow-up period) with a 
performance similar to lumbar spine BMD, but it was also independent of 
spine BMD in its predictive ability in multivariate analysis. 
6.5.3 ASSOCIATIONS AMONGST THE VARIOUS SKELETAL 
MEASURES 
Of the SMCM indices AMCI had the strongest correlations with hip and 
forearm BMD. In fact, AMCI also had better correlations with DXR indices 
than NDMCI, although the DXR indices were also measured only from the 
non-dominant side. This is again possibly because AMCI is a composite 
measurement from six metacarpals reducing the measurement error and 
regressing it more towards true skeletal strength. However, there was high 
correlation between AMCI and NDMel (r=0.93) and this was better than 
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that with DXR-MCI for either (r=0.86 and 0.81 respectively). The 
correlation between forearm BMD and AMCI (r=0.56) was slightly better 
than that reported previously between forearm BMD and MCI by the Teijin 
Bonalyzer® (r=0.50) (Dey, McCloskey et al. 2000), but somewhat worse 
than that reported by Bouxsein et al between distal radius BMD and DXR-
BMD (r=0.68) (Bouxsein, Palermo et al. 2002), and that reported earlier in 
Chapter 4 between forearm BMD and OXR-BMO, and between forearm 
BMD and DXR-MCI from the HIPS cohort (r=0.71 and 0.68 respectively, 
Table 4.7). 
The mean OXR-MCI was significantly lower than the mean NDMCI 
measured from the same side despite the correlation being high. This is 
most likely because the difference is systematic, and similar to the 
systematic discrepancy noted previously with MCI by SMCM and the Teijin 
Bonalyzer® (mean, 0.44 and 0.36 respectively, P<0.001) (Dey, McCloskey 
et al. 2000). This is likely to be because the measurements are acquired 
somewhat differently by different methods. DXR cortical thickness and 
bone width measurements are averaged over much longer regions of 
interest (ROI). For example, the measurement ROlon the shaft of the 
second metacarpal is 2.0 cm long (Bouxsein, Palermo et al. 2002). 
Anatomically, the thickest part of the cortex of a tubular bone is in the mid-
shaft or diaphysis, gradually thinning out towards the metaphysis, while 
the bone width is lowest at middle of the diaphysis and gradually increases 
towards the metaphysis. Therefore, the longer segments measured in 
DXR are likely to give, on averageing, lower cortical thickness and higher 
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bone width, compared to the midshaft measurements of SMCM, resulting 
in lower DXR-MCI. 
6.5.4 POTENTIAL LIMITATIONS 
The setting for the study was a trial of clodronate, which could have 
affected the fracture predictive ability of baseline measures. However, 
clodronate had no significant effect on hip and axial fractures. Although 
there was a protective effect on appendicular fracture and overall fracture 
incidence, DXA and SMCM measures remained significantly predictive of 
fracture risk after adjustment for clodronate treatment in logistic regression 
models. 
The median follow up was relatively short (4 years). Bouxsein et al 
reported that metacarpal measures were predictive of fracture over a 
similar follow up period (Bouxsein, Palermo et al. 2002), and Bach-
Mortensen et al reported predictive ability over a somewhat longer mean 
follow up of 6.1 years (Bach-Mortensen, Hyldstrup et al. 2006). The ability 
of MCM in predicting longer term fracture risk is unknown, but this is likely 
to be similar to that of other peripheral measures such as forearm BMD 
with which it correlates well. For example, forearm BMD has been shown 
to be predictive of fracture risk over a 25 year period (Duppe, Gardsell et 
a\. 1997). 
As mentioned previously, a fairly large intra-observer reproducibility error 
with SMCM has been reported previously for MCI from a single metacarpal 
which may compromise its utility in a clinical setting (Dey, McCloskey et al. 
2000). However, AMCI, a six-metacarpal measure, seems to have 
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improved correlation with other established skeletal measures without 
compromising the fracture predictive ability. 
6.6 CONCLUSIONS 
In this prospective study, we found that a new, rapid, semi-automated 
MCM technique predicts future risk of fracture. Although forearm BMD and 
AMCI were similarly predictive of appendicular fractures, the fracture 
predictive ability of hip and forearm BMD by DXA remained superior 
overall for all fractures, including clinical vertebral fractures where SMCM 
indices were not predictive. 
The results suggest good evidence for the use of AMCI by SMCM as an 
alternative peripheral measure of skeletal strength especially where other 
measures of skeletal assessment are not available. It may also have a 
screening role in identifying those who might be referred for axial DXA. 
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7 EFFECTS OF PRE-EXISTING MEDICAL 
CONDITIONS ON METACARPAL RADIOGRAPHIC 
INDICES 
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7.1 ABSTRACT 
Introduction: Several medical conditions may affect the peripheries, but 
their effect on peripheral bone strength measurements has been poorly 
studied. In this study, the distribution of measurements with dual-energy x-
ray absorptiometry (DXA) , a semi-automated metacarpal morphometry 
(SMCM) technique, and digital x-ray radiogrammetry (OXR) were studied 
in elderly women with respect to medical history. 
Methods: The MRC HIPS study was a community based study of risk 
factors for hip fractures in elderly women, combined with a placebo 
controlled trial of cJodronate (Bonefos®). Self-reported medical history was 
recorded at study entry. Baseline measurements included hip and forearm 
OXA and hand radiographs for SMCM and OXR. 4929 participants had 
non-dominant hand and average-of-both-hands metacarpal cortical indices 
(NO-Mel & AMCI) measured using a locally developed SMCM technique. 
687 randomly selected participants also had OXR bone mineral density 
(OXR-BMO) & OXR-MCI measured. 
Results: 
SMCM cohort: Compared to the whole cohort, hip & forearm OXA and 
AMCI & NO-MCI were lower in rheumatoid arthritis (RA), current 
glucocorticoid (GC) use, and RA+GC use (P<0.05), and were higher in 
type 2 diabetes (P<0.01). Hip & forearm OXA were slightly higher in 
hypothyroidism, while AMCI & NO-MCI were slightly lower with a history of 
stroke (P<0.05). When the measures were converted to standard deviation 
units (cohort Z scores) the largest magnitude for the measures (in either 
positive or negative direction) was seen with RA+GC use (hip DXA -0.53, 
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forearm DXA -0.82, AMCI -1.14, NO-MCI -1.09) and least with OA 
(+0.04, +0.04, -0.01 & -0.01 respectively). 
DXR cohort: RA, CS use, and RA+GC use had lower forearm DXA and 
DXR indices (P<0.05). Trends in other conditions were similar to that in 
the larger cohort but did not reach significance. Cohort z-scores were 
similarly largest for all measures with RA+GC use, and least in OA. When 
changes were converted to standard deviation units with respect to peak 
bone mass (T scores), the whole cohort's mean T scores were hip OXA-
1.64, forearm OXA -2.66 and DXR-BMD -2.97. Changes were largest 
with RA+GC use (-2.4, -4.15 & -5.09 respectively), and least for hip OXA 
with stroke (-1.49), for forearm DXA with hypothyroidism (-2.5), and for 
DXR-BMO with Parkinson's (-2.68). 
Conclusions: In this study, there was a trend for disproportionately 
greater bone loss with age at the metacarpal site compared to the hip and 
forearm. In some medical conditions there is an even greater discrepancy 
in the MCM measures suggesting a disease related bone loss or gain 
compared to the mean at the periphery. The trends were significant with 
forearm and metacarpal indices in RA where, in fact, forearm BMO was 
the strongest predictor of all fracture risk, while hip BMO was the strongest 
predictor of all fracture risk in the whole cohort. These factors will need to 
be taken into account when reporting and interpreting MCM indices, 
especially when they are likely to be used as stand alone services. 
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7.2 INTRODUCTION 
Although a significant proportion of osteoporosis in the community is post-
menopausal or senile in etiology, it often occurs as a consequence of, or is 
accelerated by other conditions such as medical diseases or drug 
exposures (Johnson, Lucasey et al. 1989). Medical conditions have also 
been shown to be associated with fracture risk itself independent of bone 
mineral density (SMO). Rheumatoid arthritis (RA) has been shown to be 
associated with osteoporosis in early and late disease (Gough, Lilley et al. 
1994; Shenstone, Mahmoud et al. 1994). Increased hip and vertebral 
fracture risk in RA has been reported previously, particularly when treated 
with glucocorticoids (Cooper, Coupland et al. 1995; Peel, Moore et al. 
1995). Increased bone loss, with resulting osteoporosis and increased 
fracture risk, has also been documented with corticosteroid therapy 
independent of underlying disease (van Staa, Leufkens et al. 2002). 
A significant proportion of patients with stroke have been shown to be 
osteoporotic at stroke-onset (Watanabe 2004). Stroke has also been 
shown to be associated with accelerated bone loss post-stroke with 
increased fracture risk (Poole, Reeve et a!. 2002). Type 1 diabetes 
mellitus (OM) is associated with modest bone loss while type 2 OM is 
associated with increased BMD (Schwartz 2003). However, more recently 
both type 1 and type 2 OM have been shown to be associated with 
increased fracture risk (Nicodemus and Folsom 2001; Schwartz, 
Sellmeyer et al. 2001). In hyperthyroidism an increased fracture risk has 
been reported as a result of bone loss and osteoporosis, while in 
hypothyroidism an increased fracture risk has been reported despite 
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normal or increased bone density (Vestergaard, Weeke et al. 2000; 
Lakatos 2003). 
Measurement of BMD by dual-energy x-ray absorptiometry (DXA) at the 
spine or hip has been the reference standard for the diagnosis of 
osteoporosis and estimation of fracture risk (Kanis 1994). However, setting 
up and running a full-fledged DXA service can be a significant expense, 
and this has been a limiting factor in the provision of osteoporosis services 
in many parts of the world. Therefore, technologies with cost, space and 
portability advantages are being developed for the assessment of 
osteoporosis and prediction of fracture and are becoming more widely 
available. Metacarpal morphometry (MCM) was one of the earliest 
methods described for systematically assessing bone strength from hand 
radiographs (Barnett and Nordin 1960). However traditional MCM was 
tedious and time consuming involving several measurements with callipers 
and manual calculation of metacarpal cortical index (Mel) and did not 
achieve mainstream recognition. More recently, a semiautomated MCM 
(SMCM) technology which was developed in-house in Sheffield at the 
WHO Collaborating Centre has been described previously (Dey, 
McCloskey et al. 2000), and its performance in fracture prediction was 
described in Chapter 6. A commercial digital x-ray radiogrammetry (DXR) 
system has also recently been available which uses fully automated MCM 
to derive MCI and DXR-BMD (Jorgensen, Andersen et al. 2000), and its 
performance in fracture prediction has been described in Chapters 4 and 
5. 
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With greater availability, peripheral bone strength assessing technologies 
including those based on MCM are beginning to be used more frequently 
in the provision of osteoporosis services. Several medical conditions such 
as those discussed above may affect the peripheries, but their effect on 
peripheral bone strength measurements, and consequently on fracture 
prediction, has been poorly studied. Measurements with DXA at the hip 
and forearm, an in-house SMCM technique, and a commercially available 
DXR system in elderly women with respect to medical history were 
compared in this study. 
7.3 METHODS 
7.3.1 SUBJECTS 
This analysis was carried out on the data from participants in the MRC Hip 
Fracture Prevention Study (HIPS). This was a Sheffield, UK, based study 
of risk factors for hip fracture in elderly women, combined with a double-
blind placebo-controlled trial of the oral bisphosphonate, clodronate 
(Bonefos®). 5212 community dwelling women aged 75 years or over were 
recruited to the study. They received either oral clodronate 800 mg daily or 
identical placebo daily for 3 years and were followed for up to a further 2 
years. At baseline extensive data were collected including self-reported 
medical history. 
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7.3.2 DESIGN 
The current analysis was performed on 4929 women from the HIPS cohort 
who had SMCM measurements (described below) from hand radiographs. 
687 participants from the HIPS who were pre-selected for other nested 
case-control analyses also had DXR measurements from the hand 
radiographs, and analysis of DXR indices from this subgroup also is 
presented. 
7.3.3 MEASUREMENTS I INVESTIGATIONS 
All subjects had height and weight measured, and had baseline hand 
radiographs taken at study entry. 
7.3.3.1DXA 
Total hip and distal forearm BMD was measured on the non-dominant side 
by Hologic QOR4500A (Hologic Inc., Bedford, USA), and Osteometer DTX 
200 (Osteometer, Hawthorne, USA) respectively. 
7.3.3.25emi-automated metacarpal morphometry 
An in-house technique developed in Sheffield and described previously 
was used (Dey, McCloskeyet al. 2000). A transparent cross-hair cursor 
with click buttons and a back-lit digitising tablet were developed for 
capturing measurements automatically on to an electronic database. The 
hand radiograph was placed on the digitising tablet and the cursor was 
moved on the regions of interest. The distance between any two points 
was measured by clicking the cursor on the first pOint and dragging it over 
the digitising tablet to the second point and clicking a second time, the 
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distance between the two clicks being recorded electronically in the 
database. The software program algorithm allowed for a set sequence of 
measurements to be taken with a series of clicks without any further 
operator input. 
Measurements of length, medial and lateral cortical thicknesses and total 
bone width of the second, third and fourth metacarpals were captured from 
both hands. The data were subsequently transferred to the SPSS version 
11 statistical package for processing and analysis. 
The cortical index (CI) of a tubular bone is calculated as follows: CI :: 2t1W, 
where 'f is the cortical thickness and 'W' is the bone width. The 
metacarpal cortical index is calculated as the weighted average of the 
cortical indices of the middle 3 metacarpals as follows: MCI:: 
(CI2+CI3+0.5CI4)/2.5. 
The MCI's for both the dominant (OMCI) and non-dominant (NOMCI) 
hands were calculated and an average MCI was calculated as follows: 
AMCI=(OMCI+NOMCI)/2. 
7.3.3.30XR measurements 
DXR measurements were obtained from the non-dominant hand in the 
hand radiograph using the Pronosco X-posure System® version 2.0 
(Sectra-Pronosco, Denmark). This system uses a high resolution scanner 
for scanning the hand radiograph and the data are processed in a 
dedicated computer. The software automatically identifies the regions of 
interest for measurement and the output indices are DXR-MCI which is 
computed as above, and OXR-BMD which is computed as follows: OXR-
BMO:: C 1T t (1 - t /W), where 't' is the average cortical thickness, 'W'the 
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average bone width and 'c' is a constant representing the average mineral 
mass I unit volume of compact bone (Rosholm, Hyldstrup et al. 2001). 
7.3.4 STATISTICS 
The primary data from HIPS as well as the metacarpal radiographic data 
were collected initially on Microsoft Access based databases. The data 
were processed and analysed using the SPSS® version 11.x statistical 
package. Baseline measurements were compared using ANOVA and Chi-
square tests. Measurements were also converted to standard deviation 
(SO) units and the magnitude of variation amongst the skeletal measures 
in each medical condition was studied using paired t-tests and Wilcoxon 
signed rank tests. Gradients of risk for future fracture with 1 SO decrease 
in measurement were calculated using regression models. Correlations 
between various measures were expressed as Pearson coefficients. A P 
value of <0.05 was considered significant. 
7.4 RESULTS 
SMCM measurements were compared to OXA measurements in various 
conditions in the larger cohort and are presented first. OXR measurements 
available in the smaller subgroup were compared with OXA and are 
presented separately below. 
Medical conditions considered included any history of RA, OA, current 
glucocorticoid use (CS use) for any reason, stroke, Parkinson's disease 
(PO), type 1 diabetes, type 2 diabetes, hypothyroidism, and 
hyperthyroidism. 
Metacarpal Radiographic Indices In Bone Assessment 136 
7.4.1 SMCM COHORT: SMCM AND DXA INDICES 
7.4.1.1 Baseline characteristics 
Compared to the rest of the cohort, total hip BMO, forearm BMO, and 
AMCI were lower in RA, CS use, and RA+GC use (all P<O.05), and were 
higher in OA and type 2 diabetes (P<O.01) (Table 7.1). Hip and forearm 
BMO were slightly higher in hypothyroidism, while AMCI was slightly lower 
with a history of stroke (P<O.05). There were also statistically significant 
differences in one or more extra-skeletal variables (age, height and 
weight) in RA, RA+GC, OA, type 2 OM and hypothyroidism when 
compared to the rest of the cohort. 
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Table 7.1. SMCM cohort: DXA & SMCM indices in various clinical conditions (mean ± SO). 
No. Age Height Weight T. hip BMD Forearm BMD AMCI 
(yrs) (cm) (kg) (gcm-2 ) (gcm-2 ) 
Total cohort 4929 79.5±3.9 155.9±6.1 65.1±12.1 0.75±0.14 0.34±0.OB 0.49±0.07 
RA 9B 79.5±4.0 155.4±6.3 62.3±11.7a O.70±O.14b O.32±O.OBb O.44±O.09b 
Current GC use 164 7B.9±3.3 155±6.0 63.B±13.2 O.72±O.14b 0.32±O.OBb 0.46±O.OBb 
RA+GC 29 79.1±3.B 154±6.4 59.1±B.5a O.6B±O.12a 0.2S±O.06b O.41±O.09b 
OA 3435 79.7±4.0b 155.7±6.1a 66.1±12.3b O.76±O.14b 0.34±0.OSb 0.49±0.07 
Stroke 122 SO.2±4.1a 155.5±6.6 66±13.1 0.73±O.16 0.33±0.OB 0.4B±0.07a 
Parkinson's 43 79.6±3.7 153.6±7.1a 62.6±15.4 O.74±O.16 0.33±0.OB 0.4B±O.09 
Type 1 DM 40 7B.8±3.7 157.2±6.6 72.B±14.2b 0.77±O.18 0.36±0.09 O.48±0.OB 
Type 2 DM 222 79.S±4.0 155.6±6.5 6B.B±12.7b 0.81±O.15b 0.37±0.OSb O.51±0.07b 
Hypothyroidism 416 79.3±4.0 156.3±6.0 6B.1±13.0b 0.77±0.14a 0.35±0.08b O.50±0.07 
Hyperthyroidism 47 SO.1±4.0 156.4±6.2 62.4±10.0 O.72±0.14 0.32±0.OB O.4B±O.07 
- --
ap<0.05, and bp::::;0.001 by ANOVA compared to rest of cohort. 
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The differences in the mean skeletal measures in these conditions were 
studied in linear regression to determine significance with respect to extra-
skeletal variables (Table 7.2). After adjustment for significant extra-skeletal 
variables, Beta coefficients for hip BMD, forearm BMD and AMCI in RA, 
and for forearm BMD and AMCI in RA+GC remained significantly lower 
compared to the total cohort. Similarly, in type 2 DM, Beta coefficients 
remained significantly higher for all three skeletal measures compared to 
mean cohort values after adjustment for significant extra-skeletal 
variables. Beta coefficients were no longer significant in OA and 
hypothyroidism after adjustment for extra-skeletal variables. 
Table 7.2. Differences in mean skeletal measures in selected 
conditions compared to mean cohort values expressed as Beta 
coefficients in linear regression: Unadjusted (univariate) and 
adjusted (multivariate) for significant extra-skeletal variables (one or 
more of age, height and weight as appropriate). 
Hip BMD Forearm BMD AMCI 
Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted 
RA -0.056b -0.041b -0.026a -0.017a -0.055b -0.052b 
RA+GC -0.075a -0.041 -0.063b -0.043b -0.080b -0.073b 
OA 0.017° 0.001 0.01° 0.001 - -
Type 2 OM 0.062b 0.04b 0.035b 0.023b 0.021b 0.017b 
Hypothyroidism 0.017a 0.001 0.014b 0.003 - -
a 01 P<0.05 and P<0.001. 
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7.4.1.2Comparison of cohort Z scores in various medical 
conditions 
When the measurements were converted to standard deviation units 
(cohort Z scores) the largest magnitude (either positive or negative) in the 
scores was seen with RA+GC use (hip DXA -0.53, forearm DXA -0.82, & 
AMCI -1.14) and least with OA (+0.04, +0.04, & -0.01 respectively) (Table 
7.3). AMCI Z scores were significantly lower than hip Z scores in RA and 
RA+GC subgroups, and significantly lower than forearm Z scores in RA, 
type 1 OM and type 2 OM subgroups (paired t tests, P<0.05). Similar 
findings were noted with OA, but the magnitude of the scores themselves 
was smallest compared to the other medical conditions as mentioned 
above, suggesting the statistical significance is secondary to the large 
numbers of patients rather than a clinically relevant difference. Although 
there were some trends towards lower AMCI Z scores in other medical 
conditions, they were not statistically significant. 
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Table 7.3. SMCM cohort: comparison of cohort Z scores [mean 
(standard error of mean)) of skeletal measures in prevalent medical 
conditions. 
Hip BMO Forearm BMO AMCI 
RA -0.39(0.10) -0.34(0.10) -0.77(O.13)a,b 
Current GC -0.26(0.08) -0.28(0.08) -0.41 (0.09) 
RA+GC -0.53(0.16) -0.82(0.16) -1.14(0.23)a 
OA 0.04(0.02) 0.04(0.02) -0.01 (0.02)a,b 
Stroke -0.16(0.11) -0.1 (0.1 0) -0.21 (0.09) 
Parkinson's -0. 11 (0. 18) -0.2(0.15) -0.21 (0.19) 
Type 1 OM 0.11(0.21) 0.22(0.19) -0.25(0.18}b 
Type 2 OM 0.42(0.07) 0.44(0.07) 0.29(0.07}b 
Hypothyroid ism 0.11 (0.05) 0.16(0.05) 0.07(0.05) 
Hyperthyroid ism -0.24(0.14) -0.21 (0.14) -0.21(0.15) 
. a • 01 Paired t-tests. P<O.05 compared to hip BMD, P<O.05 compared to forearm 
BMD. 
7.4.1.3Gradients of risk for incident fracture in SMCM 
cohort, and RA and type 2 OM subgroups (Table 7.4) 
To assess whether the significant differences amongst the three skeletal 
measures in RA were reflected in prediction of fracture risk, gradients of 
risk for incident fracture for 1 SO decrease in measurement were 
computed for the whole SMCM cohort and for the RA subgroup of the 
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SMCM cohort with adjustments for age, weight and clodronate treatment 
status. 
In the whole cohort, total hip BMD was the strongest predictor of all (any) 
fractures with the odds ratios (OR's) for t. hip BMD, forearm BMD and 
AMCI being 1.61, 1.47 and 1.26 respectively (all P<0.05). In the RA 
subgroup, forearm BMD was the strongest predictor of all fractures with 
the OR's for the three measures for all fractures being 1.63, 1.85 and 1.17 
respectively (P<0.05 for forearm BMD only). In type 2 DM, hip BMD was 
the strongest predictor with the OR's for the three measures being 1.99, 
1.81 and 1.29 respectively (P<0.05 for hip and forearm BMD only). 
Similar trends were noted for prediction of appendicular fracture. The OR's 
for appendicular fracture in the whole cohort were 1.47, 1.38 and 1.29 for 
total hip BMO, forearm BMD and AMCI respectively (all P<O.05). The OR's 
for appendicular fracture in the RA subgroup were 1.35, 1.84 and 1.15 
respectively (none significant). In type 2 OM, hip BMD remained the 
strongest predictor of appendicular fracture as well, with the OR's for the 
three measures being 1.82, 1.0 and 1.15 respectively (P<0.05 for hip BMD 
only). 
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Table 7.4. SMCM cohort: Gradients of risk for incident fracture for 1 SO decrease in skeletal measurement in whole cohort, 
and RA and type 2 OM subgroups (adjusted for age, weight and clodronate treatment; n=number of fractures). 
All fractures Appendicular fracture 
SMCM cohort RA subgroup Type 2 OM SMCM cohort RA subgroup Type 2 OM 
(n=792) (n=21) (n=32) (n=449) (n=14) (n=15) 
T. hip BMO 1.61,1.48-1.74a 1.63, 0.92-2.90 1.99, 1.35-2.92a 1.47,1.33-1.63a 1.35,0.71-2.59 1.82, 1.1 0-3.02a 
Forearm BMO 1.47, 1.35-1.59a 1.85, 1.04-3.29a 1.81,1.20-2.72a 1.38,1.24-1.53a 1.84, 0.86-3.91 1.0, 0.51-1.96 
AMCI 1.26,1.16-1.36a 1.17,0.76-1.78 1.29,0.88-1.90 1.29,1.17-1.44a 1.15, 0.70-1.86 1.15,0.68-1.95 
- - - - -
L _ 
aForward-conditional regression, P<0.05. 
7.4.1.4Correlations amongst the skeletal measures in SMCM cohort and RA subgroup 
AMCI had similar correlations with hip BMO in the whole SMCM cohort and in RA and type 2 OM subgroups (Pearson coefficients, 
r= 0.41,0.44 and 0.40 respectively, all P<0.001). AMCI had similar correlations with forearm BMO also in the SMCM cohort and RA 
and type 2 OM subgroups (r=0.56, 0.57, and 0.60 respectively, all P<0.001). However, the correlation between hip and forearm 
BMO was better in the whole SMCM cohort than in the RA subgroup, but was similar to that in type 2 OM subgroup (r=0.65, 0.51 
and 0.66 respectively, all P<0.001). 
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7.4.2 DXR COHORT: DXR AND DXA INDICES 
7.4.2.1 Baseline Characteristics 
Compared to the rest of the cohort mean forearm BMD, DXR-BMO and 
OXR-MCI were lower with RA, CS use and RA+GC use (P<O.05 for all) 
(Table 7.5). Although total hip BMD was also somewhat lower with RA, CS 
use, RA+GC use and type 10M. this did not reach significance. There 
were no significant trends with the other disorders. Although there were 
some differences in extra-skeletal variables (age, height and weight) in the 
various conditions compared to the rest of the cohort, none were 
statistically significant. 
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Table 7.S. DXR cohort: DXA measures and DXR indices in various clinical conditions (mean ± SO). 
No. Age Height Weight T. hip BMD Forearm BMO OXR-BMO OXR-MCI 
Total cohort 687 79.7±4.0 156±6.4 64.4±12.3 0.74±0.15 0.34±0.08 0.43±0.O6 O.32±O.O5 
RA 14 79.1±3.8 157.7±7.3 64.B±10.7 0.71±0.15 0.2B±0.OBb 0.40±0.07a 0.27±0.05b 
Current GC use 21 79±2.4 155.7±5.6 64.B±12.9 0.70±0.12 0.30±O.05a 0.40±O.06b 0.29±0.06b 
RA+GC 4 76±0.8 15B.2±7.1 66.7±3.0 0.65±0.O4 0.25±0.02a 0.33±0.04b 0.23±0.04b I 
OA 479 79.B±4.0 155.B±6.5 64.9±11.9 0.75±0.15 0.34±0.OBa 0.43±0.05 0.32±0.05 
Stroke 15 79.7±2.8 155.6±4.8 63.7±9.9 O.76±0.16 0.33±0.07 0.42±O.O4 O.30±0.O4 
Parkinson's 7 BO±3.6 155.6±5.0 60.9±7.4 0.76±0.10 0.33±0.07 0.45±0.06 0.32±0.05 
Type 1 OM 4 80. B±4. 8 155.6±5.5 69.2±24.0 0.66±O.20 O.37±O.14 O.44±0.O7 0.31±0.O9 
Type 2 OM 25 BO.B±4.2 155±6.5 68.3±13.9 0.75±0.12 O.34±O.07 0.42±0.05 0.31±0.05 
Hypothyroidism 61 BO.1±4.7 156±7.1 66.7±13.4 0.75±O.16 O.35±O.OB 0.44±0.O5 O.32±0.05 
Hyperthyroidism 8 77.4±2.3 157.3±6.7 65.3±10.2 0.75±O.O6 O.35±O.05 0.44±0.05 0.32±0.05 
~-
----- -- - --
L _______ 
-----
~-~~-
- - -- -- -- - - ----
ap<O.05, and bp<O.01 by ANOVA compared to rest of cohort. 
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7.4.2.2Comparison of cohort Z scores in various medical 
conditions 
Like in the SMCM group, cohort Z scores in the DXR group were of the 
largest magnitude for all measures with RA+GC use (total hip -0.64, 
forearm -1.13, DXR-BMD -1.79 and DXR-MCI -1.64); and least in OA 
(0.04, 0.05, 0.01, and 0.03 respectively) (Table 7.6). When Z scores for all 
4 indices were compared within each medical condition subgroup, forearm 
and DXR-MCI Z scores were significantly lower than total hip Z score in 
the RA subgroup (paired t-test P<0.05). Differences within other conditions 
were not significant. 
Table 7.S. DXR cohort: comparison of cohort Z scores [mean 
(standard error of mean)] of different skeletal measures in prevalent 
medical conditions. 
T. hip Forearm DXR-BMD DXR-MCI 
RA -0.21(0.28) -0.7(0.26)a -0.64(0.33) -0.8(0.28)a 
Current GC -0.31(0.18) -0.45(0.13) -0.62(0.22) -0.56(0.25) 
RA+GC* -0.64(0.15) -1.13(0.15) -1.79(0.36) -1.64(0.36) 
OA 0.04(0.05) 0.05(0.04) 0.01(0.04) 0.03(0.04) 
Stroke 0.12(0.28) -0.07(0.24) -0.28(0.18) -0.34(0.20) 
Parkinson's* 0.13(0.26) -0.14(0.33) 0.25(0.40) 0.11(0.36) 
Type 1 diabetes* -0.55(0.70) 0.41(0.91) 0.11 (0.63) -0.12(0.83) 
Type 2 diabetes 0.04(0.16) 0.1(0.19) -0.14(0.18) -0.11 (0.18) 
Hypothyroid ism 0.03(0.14) 0.12(0.14) 0.17(0.12) 0.08(0.13) 
Hyperthyroidism* 0.09(0.15) 0.24(0.25) 0.14(0.28) 0.13(0.32) 
* ap<O.05 compared to t. hip Z score by paired t-tests. Wilcoxon signed rank test. 
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7.4.2.3Comparison of T scores in various medical 
conditions 
T scores (standard deviation units compared to peak bone mass in young 
adult) were computed from manufacturer's normative databases for hip 
and forearm BMO, and from previously determined normative data with 
peak measurements for OXR-BMO (peak value for OXR-BMO occurred at 
age 38, mean = 0.598 g/cm2, standard deviation = 0.034 g/cm2) (Black, 
Palermo et al. 2001). The magnitude of the scores was largest for all three 
measures (hip BMO, forearm BMO and OXR-BMO) with RA+GC use (-2.4, 
-4.15 and -5.09 respectively); and least for hip OXA with stroke (-1.49); for 
forearm DXA with hypothyroidism (-2.5); and for OXR-BMD with 
Parkinson's (-2.68) (Table 7.7). For the whole group, forearm and OXR-
BMO T scores were significantly lower compared to hip T score (P<O.05), 
and this trend was repeated significantly with each medical condition 
except type 10M. Overall, OXR-BMO T score was also significantly lower 
than forearm T score for the whole cohort (-2.97 vs -2.66 respectively, 
P<0.05); similar trends were noted in most of the medical conditions but 
were significant only in OA, stroke, type 2 OM and hypothyroidism (all 
P<0.05). The RA subgroup within the OXR cohort was too small (n=14) 
with small fracture numbers (n=4) to meaningfully compare the 
performance of the various measures in fracture prediction. 
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Table 7.7. OXR cohort: comparison of mean T scores of skeletal 
measures (deviation from mean peak bone mass in SO units, paired 
t-tests). 
Hip BMD Forearm BMD DXR-BMD 
Whole cohort -1.64 -2.66a -2.97 a, b 
RA -1.9 -3.58a -3.73a 
Current GC -2.01 -3.26 a -3.7 a 
RA+GC -2.4 -4.15 a -5.09 a 
OA -1.6 -2.59 a -2.95 a, b 
Stroke -1.49 -2.75 a -3.3 a, b 
Parkinson's -1.49 -2.84 a -2.68 a 
Type 1 OM -2.3 -2.11 -2.84 
Type 2 OM -1.59 -2.52 a -3.13 a, b 
Hypothyroidism -1.61 -2.5 a -2.77 a, b 
Hyperthyroidism -1.53 -2.34 a -2.8 a 
. 0 
a P<0.05 compared to t.hlp T score, P<O.OS compared to forearm T 
score. 
7.4.2.4Correlations amongst the skeletal measures in the 
DXR cohort and RA subgroup 
There were significant correlations amongst the various measures. DXR-
BMD and DXR-MCI had somewhat poorer correlation with hip BMD in the 
whole DXR cohort compared to the RA subgroup (r=0.S7 and 0.69 
respectively for DXR-BMD, both P<0.01; r=0.54 and 0.61 respectively for 
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DXR-MCI, both P<0.001). Similarly, DXR-BMD and DXR-MCI had 
somewhat poorer correlation with forearm BMD in the whole cohort than in 
the RA subgroup (r=0.71 and 0.81 respectively for DXR-BMD; r=0.68 and 
0.78 respectively for DXR-MCI, all P<0.001). The difference was more 
marked in the correlations between forearm BMD and hip BMD in the 
whole DXR cohort and the RA subgroup (r=0.67 and 0.86 respectively, 
both P<0.001). Correlations between DXR-BMD and DXR-MCI however 
were similar in the whole cohort and the RA subgroup (r=0.90 and 0.96 
respectively, both P<0.001). 
7.5 DISCUSSION 
In this study the effect of medical history on peripheral bone strength 
measurements was studied and compared with the effect on hip BMD. 
Compared to the whole cohort, the deviations of bone strength 
measurements (Z scores) in the studied disorders were largely in the 
same direction irrespective of the skeletal measure used. However, there 
was a trend for the magnitude of the Z scores to be greater with peripheral 
(forearm and metacarpal) measures than with central (hip) measures. The 
trends were statistically significant with RA where in fact, forearm BMD 
was the strongest predictor of fracture risk while hip BMD was the 
strongest predictor of fracture risk in the whole cohort. 
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7.5.1 MEDICAL HISTORY 
Women with a history of RA (especially RA+GC) weighed significantly less 
at baseline and had lower bone strength measures than the rest in the 
SMCM cohort. However, even after adjusting for weight in linear 
regression, RA remained significantly associated with lower skeletal 
measures. BMD loss at the spine and at the hip in RA was reported 
previously as being related to the disease activity (Gough, Lilley et al. 
1994). More recently, DXR-BMD has been reported as being significantly 
correlated with markers of inflammation in RA (Jensen, Klarlund et al. 
2004). Bottcher et al also reported a significant reduction of DXR-BMD as 
well as DXR-MCI dependent on the severity of RA and found that DXR 
"surpassed multisite quantitative ultrasound as a promising diagnostic tool" 
for peripheral bone status in RA (Bottcher, Pfeil et al. 2006). Our finding 
that RA has a detrimental effect on skeletal measures independent of 
weight is in keeping with these previous findings. Women with a history of 
OA and hypothyroidism had one or more skeletal measures Significantly 
greater than the rest of the SMCM cohort, but this was no longer 
significant after adjustment for body weight in linear regreSSion. This 
suggests that the differences in skeletal measures were a reflection of 
associated overall body habitus rather than any independent direct effect 
of OA or hypothyroidism on bone strength. This is in contrast to the small 
study reported by Kemper et ai, where young women with cogenital 
hypothyroidsm treated with thyroxine were found to have somewhat lower 
spine BMD than controls (but comparable femoral neck BMD) (Kempers, 
Vulsma et al. 2006). However, higher skeletal measures noted in type 2 
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OM remained significant after adjustment for weight suggesting a direct 
effect on bone. This is consistent with the previous report that 
hyperinsulinemia of type 2 OM in women may be associated with raised 
BMD independent of obesity (Barrett-Connor and Holbrook 1992). 
7.5.2 T SCORES, COHORT Z SCORES AND FRACTURE RISK 
PREDICTION WITH VARIOUS SKELETAL MEASURES 
T scores in the DXR cohort suggest a trend for greater loss of bone mass 
from the forearm and metacarpal sites than at the hip with age irrespective 
of any associated medical condition. The concept of disproportionate bone 
loss at different skeletal sites has been reported previously, with the 
finding of a preferential reduction in bone mineral content at long bone 
ends compared to diaphyseal sites (femur and radius) with age (Sievanen, 
Uusi-Rasi et al. 1999). Disproportionate bone loss would also explain the 
lower mean cohort Z scores at the forearm and possibly metacarpal sites 
compared to the hip in both the cohorts. The greater loss at the peripheral 
sites is reflected in their lower fracture predictive ability with both forearm 
and metacarpal indices faring less well than hip BMD in the SMCM cohort 
as a whole. This is in keeping with a previous report that the sites with the 
strongest relationship to hip fracture (hip and the heel) showed the least 
age-related T score decline (Faulkner, von Stetten et al. 1999). 
In the RA subgroup there was an even greater statistically significant loss 
at the metacarpal site, which is probably directly related to the disease 
process itself as well as to reduced physical use of the hands. Similar 
findings have been reported previously (Jensen, Klarlund et al. 2004). This 
disproportionate loss is reflected in the lower fracture predictive ability of 
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AMCI in the RA subgroup. The higher fracture predictive ability of forearm 
BMO compared to hip BMO in RA may partly be explained by the fact that 
a somewhat greater proportion of the sustained fractures were 
appendicular fracture than that in the whole cohort. 
In type 2 OM, hip and forearm BMO had somewhat higher point estimates 
of OR's for all fractures, which is probably in keeping with their higher 
mean values compared to the rest of the cohort. AMCI on the other hand 
had a similar point estimate to the rest of the cohort despite a somewhat 
higher mean value. A greater rate of bone loss despite initial higher BMO 
in older adults with type 2 OM has been suggested as a possible 
mechanism in fracture risk (Schwartz, Sellmeyer et al. 2001). This may be 
a mechanism whereby all three skeletal measures provide similar or 
higher point estimates of risk for 1 SO decreases in measurement despite 
higher BMO at baseline compared to the rest of the cohort. 
7.5.3 POTENTIAL LIMITATIONS 
The medical history was self-reported in this study, and was not 
independently corroborated from medical records. However, a previous 
study suggested good to moderate correlation in self-reported history and 
medical records, except in some areas such as prior thyroid disease, and 
corticosteroid and anti-convulsant use (Beard, Melton et al. 1990). 
Although prior glucocorticoid use history was also available, this analysis 
included current glucocorticoid use only where reportage is likely to have 
been of higher accuracy. The rest of the medical conditions studied were 
chronic conditions, where the accuracy of history is likely to have been 
high in simply indicating the presence or absence of the condition. 
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The relatively small number of fractures studied meant that where the 
point estimates of the various OR's reached statistical significance, the 
confidence intervals were relatively wide. Although the DXR cohort had a 
similar proportion of the medical conditions as the SMCM cohort, numbers 
of subjects with the various conditions in the DXR cohort were probably 
too small to provide adequate statistical power for the current analysis. 
Some trends seen in the DXR cohort may have reached significance with 
a larger number of subjects. The setting for this analysis was a controlled 
trial of clodronate which has a bone protective effect affecting fracture 
incidence. However, this effect was minimised by adjusting for clodronate 
treatment in regression models used. 
7.6 CONCLUSIONS 
There is a trend for disproportionate bone loss at the metacarpal site 
compared to the hip as well as forearm with age. This is irrespective of any 
associated medical conditions, and this is reflected in general in the lower 
fracture predictive ability of MCM measures compared to DXA measures. 
In some medical conditions there is an even greater discrepancy in the 
MCM measures suggesting a disease related bone loss or gain at the 
periphery. However, this trend was significant only in RA demonstrating 
lower mean scores, and in type 2 OM demonstrating higher mean scores 
compared to the rest of the cohort, and this is reflected in the differences 
in fracture predictive abilities of the measures when compared to the 
whole cohort. These factors will need to be taken into account when 
reporting and interpreting MCM indices, especially when they are likely to 
be used as stand alone services. 
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8 SUMMARY & OVERALL CONCLUSIONS 
Metacarpal Radiographic Indices In Bone Assessment 
The findings from the various projects are summarised below, with 
reference to the objectives for the study stated in Chapter 3. The final 
conclusions are included based on these findings, and address the 
hypothesis for the study stated in Chapter 3. 
8.1 DXR IN FRACTURE PREDICTION 
8.1.1 HIP FRACTURES 
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• In univariate analyses from the HIPS study (Chapter 4), the odds ratios 
(DRs) for hip fracture per 1SD decrease in DXR-BMD and DXR-MCI 
were 1.79, 1.47-2.19 and 1.72, 1.41-2.11 respectively. 
• Both were similar to the OR calculated for forearm BMD of 1.90, 1.55-
2.34 but less than the OR calculated for total hip BMD of 2.33, 1.87-
2.90. 
• Following adjustment for clinical predictors (age and body weight), 
DXR indices remained significant predictors of hip fracture (1.46, 1.17-
1.81, and 1.43, 1.15-1.76, respectively). They were comparable to that 
of forearm BMD (1.51, 1.19-1.91) but were lower than that for total hip 
BMD (1.98, 1.56-2.50). 
• The point values of the OR's for both DXR indices and DXA measures 
were somewhat higher for the trochanteric fracture subgroup compared 
to the femoral neck fracture subgroup. 
• In multivariate analyses, DXR indices were not independent of forearm 
BMD or hip BMD in predicting hip fracture. 
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8.1.2 VERTEBRAL FRACTURES 
• In univariate analysis from the Vertebral Osteoporosis Trial (Chapter 
5), the gradients of risk per 1 SO decrease (DRs, 95%CI) for incident 
vertebral fractures were similar for lumbar spine BMO and DXR-MCI 
(1.82,1.37-2.43 and 1.81, 1.37-2.39 respectively). 
• These were somewhat higher than that for DXR-BMD and total hip 
BMD (1.56,1.23-1.96, and 1.46, 1.16-1.96 respectively). 
• In multivariate analysis, the baseline presence of vertebral fracture, 
lumbar spine BMD and DXR-MCI were all Significant independent 
predictors of future vertebral fracture with DRs of 6.84, 3.66-12.78 for 
prevalent vertebral fracture; 1.56, 1.17-2.07 for lumbar spine BMO; and 
1.47, 1.04-2.07 for OXR-MCI. 
8.2 SMCM IN FRACTURE PREDICTION 
8.2.1 ALL (ANY) OSTEOPOROTIC FRACTURES 
• In univariate analysis from the HIPS study (Chapter 6), the gradient of 
risk for all (any) fractures (odds ratio, 95% CI) for 1 SO decrease in 
AMCI (6 metacarpal index) was 1.30, 1.20-1.40. 
• The corresponding OR for total hip BMO was 1.61, 1.49-1.74, and for 
forearm BMO was 1.47, 1.35-1.59, both being higher than that with 
AMCI. 
• The gradients of risk with AMCI were either similar or higher than with 
unilateral MCI. 
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• After adjusting for significant extra-skeletal variables, AMCI remained 
significantly associated all fractures. 
• SMCM indices were not significantly predictive of incident clinical 
vertebral fractures. 
• After adjusting for total hip BMD, AMCI or the other SMCM indices 
were not significantly predictive of all fracture risk. 
8.2.2 HIP FRACTURES 
• In univariate analysis from the HIPS study (Chapter 6), the gradient of 
risk for hip fracture for 1 SD decrease in AMCI was 1.42, 1.22-1.65. 
• The corresponding OR for total hip BMD was 2.09, 1.80-2.43, and for 
forearm BMD was 1.79, 1.52-2.11, both somewhat higher than that 
with AMCI. 
• After adjusting for significant extra-skeletal variables, AMCI remained 
significantly associated with hip fracture risk. 
• After adjusting for total hip BMD, AMCI or the other SMCM indices 
were not significantly predictive of hip fracture risk. 
8.3 CORRELATIONS BETWEEN VARIOUS SKELETAL 
MEASURES 
8.3.1 DXR INDICES 
• In the hip fracture analysis from the HIPS cohort (Chapter 4), DXR-
BMD had significant correlations with total hip BMD and forearm BMD 
(r=0.57 and 0.71 respectively). DXR-MCI also had similar correlations 
with total hip and forearm BMD (r=0.54 and 0.68 respectively). 
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• In the vertebral fracture analysis from the VOT cohort (Chapter 5), 
DXR-BMD had significant correlations with total hip BMD and lumbar 
spine BMD (r=0.53 and 0.37 respectively). DXR-MCI also had similar 
correlations with total hip and lumbar spine BMD (r=0.51 and 0.34 
respectively). 
• The correlations between DXR-BMD and DXR-MCI were very similar in 
the HIPS and VOT studies (r=0.90 and 0.89 respectively). 
8.3.2 SMCM INDICES 
• In the analysis from the HIPS cohort (Chapter 6), AMCI had significant 
correlations with total hip BMD and forearm BMD (r=0.41 and 0.56 
respectively). 
• AMCI also had Significant correlations with DXR-BMD and DXR-MCI 
(r=0.73 and 0.86 respectively). 
8.4 PRE-EXISTING MEDICAL CONDITIONS AND MCM 
8.4.1 RHEUMATOID ARTHRITIS 
• In multivariate analyses of the SMCM cohort of HIPS (Chapter 7), in 
the RA subgroup forearm BMD was found to be significant independent 
predictor of all fractures (1.85, 1.04-3.29), but total hip BMD and AMCI 
were not independent predictors (1.63, 0.92-2.90 and 1.17, 0.76-1.78 
respectively) . 
• In the SMCM cohort, compared to other medical conditions, the 
RA+current glucocorticoid (RA+GC) subgroup had the lowest mean 
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cohort Z scores for hip BMD (-0.53), forearm BMD (-0.82) and AMCI (-
1.14, P<0.05 compared to mean hip BMD Z score). 
• In the DXR cohort, compared to other medical conditions, the 
RA+current glucocorticoid (RA+GC) subgroup had the lowest mean T 
scores for hip BMD (-2.3), forearm BMD (-4.15, P<0.05 compared to 
mean hip BMD T score) and OXR-BMD (-5.09, P<0.05 compared to 
mean hip BMD T score). 
8.4.2 TYPE 2 DIABETES MELLITUS 
• In multivariate analyses of the SMCM cohort of HIPS (Chapter 7), in 
the type 2 OM subgroup total hip BMO and forearm BMO were found to 
be significant independent predictor of all fractures (1.99, 1.35-2.92, 
and 1.81, 1.20-2.72 respectively), but AMCI was not an independent 
predictor (1.29, 0.88-1.90). 
• In the SMCM cohort, compared to other medical conditions, the Type 2 
DM subgroup had the highest mean cohort Z scores for hip BMD 
(+0.42), forearm BMD (+0.44) and AMCI (+0.29, P<0.05 compared to 
mean forearm BMD Z score). 
• In the DXR cohort, the type 2 DM subgroup's mean T scores showed a 
disproportionate bone loss in the peripheral measures, with the mean 
scores being, for hip BMD -1.59, forearm BMD -2.52 (P<0.05 
compared to mean hip BMD T score) and DXR-BMD -3.13 (P<0.05 
compared to mean hip and forearm BMD T scores). 
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8.4.3 OTHER MEDICAL CONDITIONS 
• In the analyses from the HIPS cohort (Chapter 7), in the other medical 
conditions studied there was a general trend for disproportionately 
greater bone loss with age at the metacarpals (by MCM measures) 
compared to the hip or forearm by DXA. 
8.5 OVERALL CONCLUSIONS 
In the described projects, both DXR and SMCM indices were found to be 
predictive of future osteoporotic fracture risk in general, even after 
adjusting for extra-skeletal risk factors, and had moderate to good 
correlation with DXA measures. Specifically, DXR indices were shown to 
be predictive of incident hip and vertebral fractures, with DXR-MCI being 
an independent predictor of vertebral fracture. However, overall, 
metacarpal radiographic (MCM) indices were not superior to DXA 
measures in fracture prediction, and the gradients of risk for all fractures, 
and hip and vertebral fractures were higher for the DXA measures 
compared to the MCM indices. 
Although DXA has largely replaced other bone strength assessing 
technologies in health systems of developed countries, it is still relatively 
expensive. The MCM technologies studied here are compact, easy to set 
up and run, and are also relatively inexpensive compared to a full-fledged 
DXA scanner. A role for these systems could be justified: 1) in 
epidemiological studies of osteoporosis; 2) as a clinical service where DXA 
services are unavailable, and 3) in some clinical conditions affecting the 
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spine and pelvis where spine and hip DXA measurements might be 
uninformative or less informative such as ochronosis, Paget's disease, 
previous orthopaedic surgery etc. 
However, when interpreting and reporting measurements from these MCM 
technologies, the trend found in this study for disproportionately greater 
bone loss at the metacarpals compared to hip and even forearm DXA will 
need to be taken into account. especially when there are also medical risk 
factors associated such as rheumatoid arthritis etc. 
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